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Abstract 
Exposure with Acceptance-Based versus Habituation-Based Rationale For Public 
Speaking Anxiety 
Erica L. England 
James D. Herbert 
Evan M. Forman 
 
Social Anxiety Disorder (SAD) is a potentially debilitating condition affecting 
approximately 12% of the population at some point in their life (Ruscio et al., 2008). 
SAD is divided into two subtypes: generalized and nongeneralized. Nongeneralized SAD 
refers to individuals whose fears are limited to one or two social situations, most 
commonly public speaking. Empirically supported treatments for public speaking anxiety 
generally include an exposure component (usually in vivo/simulated exposure). Exposure 
is often presented within the context of a habituation rationale, but cognitively- based 
therapies utilize a rationale for exposure based on cognitive restructuring and belief 
modification. Research investigating the incremental benefit of adding other treatment 
components to exposure has yielded mixed results; however, there is preliminary 
evidence that the context in which exposure is presented can have an impact on treatment 
outcome. Recently, acceptance-based therapies have begun to frame exposure as an 
opportunity to increase one’s willingness to experience anxiety while engaging in valued 
behaviors, rather than as a vehicle for modifying maladaptive cognitions and reducing 
anxiety. However, little research has been conducted on the efficacy of acceptance-based 
therapies for public speaking anxiety, and no component control studies have examined 
the utility of an acceptance/cognitive defusion rationale and context for exposure. The 
present study compared exposure within an acceptance/defusion context to exposure with 
a habituation-based rationale in the treatment of public speaking anxiety. Treatment was 
  
x 
delivered in a group format over 6 weekly sessions. The hypothesis of superior outcomes 
for the acceptance-based group was not supported by the data; no significant differences 
were found between the two treatment conditions. All participants improved on outcome 
measures of social/public speaking anxiety and speech quality (social skills). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
  
1 
CHAPTER 1: INTRODUCTION 
Social anxiety disorder (SAD), also referred to as social phobia, is characterized 
by a persistent fear of humiliation or embarrassment in social situations (Diagnostic and 
Statistical Manual of Mental Disorders, 4th ed., text revision; DSM-IV-TR; American 
Psychiatric Association [APA], 2000). The disorder tends to follow a chronic course, 
usually beginning by early adolescence (Wittchen & Fehm, 2003). Estimates of the 
lifetime prevalence of SAD range from 3-13% of the general population (APA, 1994); 
the recent National Comorbidity Survey Replication (NCS-R) estimated the lifetime 
prevalence of the disorder at 12.1% (Ruscio et al., 2008). SAD is typically associated 
with significant functional impairment and high rates of comorbidity (e.g., Vriends, 
Becker, Meyer, Michael, & Margraf, 2007). Individuals with SAD typically avoid feared 
social situations, or otherwise participate in them with severe anxiety (Turk, Heimberg, & 
Hope, 2001). Impairment is evident in both occupational and social settings; individuals 
with SAD are less likely than individuals with other anxiety disorders to be married 
(Sanderson, DiNardo, Rapee, & Barlow, 1990) and are often unemployed or 
underemployed (Turk et al., 2001).  
Data from the NCS-R (Ruscio et al., 2008) indicate that nearly two-thirds of 
individuals with SAD meet criteria for at least one comorbid DSM-IV disorder, and that 
rates of comorbidity are positively correlated with the number of feared situations. The 
most common comorbid disorders are other anxiety disorders, followed by mood 
disorders (Ruscio et al.; M. B. Stein & Chavira, 1998); comorbidity also exists with 
impulse-control and substance use disorders (Ruscio et al.). Due in part to overlapping 
diagnostic criteria, SAD is highly comorbid with avoidant personality disorder, 
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particularly in more severe cases (e.g., Herbert, Hope, & Bellack, 1992; Turner, Beidel, 
& Townsley, 1992). Onset of SAD tends to predate that of comorbid disorders (Kessler, 
Stein, & Berglund, 1998). 
 People suffering from SAD often go untreated, in part because seeking treatment 
constitutes a feared social situation for many people with SAD (M. B. Stein & Chavira, 
1998). Additionally, treatment resources for SAD are very limited, due to barriers such as 
lack of insurance coverage and inadequate awareness of SAD by health care 
professionals (Olfson et al., 2000). In particular, although empirically supported 
treatments for SAD exist, they are often unavailable due to various factors, such as a lack 
of professionals qualified to deliver such treatments. A study conducted by the 
Harvard/Brown Anxiety Disorders Research Program revealed that only 34% of a treated 
sample (including generalized anxiety disorder, panic disorder, and social phobia) had 
received a form of cognitive or behavioral therapy (Goisman, Warshaw, & Keller, 1999). 
Epidemiological studies (Kessler et al., 1998; Ruscio et al., 2008) indicate that 
approximately two-thirds of lifetime social phobics receive no treatment specifically for 
their social anxiety, and one-third never receive any mental health treatment whatsoever. 
Although people with more generalized social anxiety (i.e., a greater number of feared 
social situations) are more likely to receive treatment than those with fewer feared 
situations, the reverse is true in cases without a comorbid disorder (Ruscio et al.). Thus, a 
significant percentage of people with potentially incapacitating SAD are not being 
treated. 
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1.1. Distinction Between Generalized Social Phobia and Public Speaking Anxiety 
 The most recent versions of the Diagnostic and Statistical Manual of Mental 
Disorders (DSM-IV-TR, APA, 2000; DSM-IV, APA, 1994; DSM-III-R, APA, 1987) 
include a “generalized” subtype, distinguished by a fear of “most social situations.” The 
lack of specification of what constitutes “most” situations has led to a proliferation of 
proposed classification systems. These include detailed distinctions between generalized 
and nongeneralized or specific social phobia (see Hook & Valentiner, 2002), subtype 
models based on types of situations feared (e.g., Eng, Heimberg, Coles, Schneier, & 
Liebowitz, 2000; Holt, Heimberg, Hope, & Liebowitz, 1992), and continuum models 
reflecting number of situations feared and level of impairment (Ruscio et al., 2008; 
Vriends et al., 2007).  
 Prior to the publication of the DSM-IV, several subtyping options were suggested 
in order to clarify the distinction between generalized and nongeneralized social phobia. 
Heimberg and Holt (1989) proposed a three-subtype model of the disorder. Their division 
consisted of a generalized group (those comprised of people who fear most social 
situations), a circumscribed group (those who fear a limited number of discrete 
situations), and an intermediate group referred to as nongeneralized (people who fear less 
than most but more than one or two situations, including social interaction situations). 
The DSM-IV social phobia subworkgroup (Task Force in DSM-IV, APA, 1991) also 
considered a three-subtype model, based upon the types of situations feared. Their 
proposed subtypes included a Generalized Type (fears of most social situations), a 
Limited Interactional Type (fears of one or two social interaction-related situations), and 
a Performance Type (fears limited to public speaking and performance situations). These 
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classification systems were ultimately rejected from consideration for the DSM-IV 
because there was insufficient data to support them (Schneier et al., 1998). 
 Turner and colleagues (1992) divided their clinical sample into specific and 
generalized subtypes of social phobia based on the types of situations feared. Individuals 
were assigned the specific subtype if they feared only performance-oriented situations 
such as giving speeches or speaking in meetings, or other circumscribed situations, 
including eating or writing in public and using public restrooms. The generalized subtype 
was used to identify those who feared most commonly occurring social situations 
(conversations, parties, etc).  Thus, instead of defining “generalized” as “most situations” 
and “specific” as “only one or two situations,” the generalized and specific subtypes were 
differentiated according to the frequency with which the feared situations typically occur. 
Those who feared more commonly occurring, interaction situations were considered to 
have generalized social phobia, whereas those with more circumscribed, performance-
type situational fears were assigned the specific subtype. Similarly, in their review of 
social phobia studies, Hook and Valentiner (2002) propose a qualitative distinction 
between generalized and specific social phobia based in part on the types of situations 
(i.e., interaction versus performance) in which the fear occurs. 
 A change in the social phobia subtyping scheme is proposed for the DSM-V. 
Instead of the optional specifier “generalized,” diagnosticians will be able to add the 
classification “performance only” for individuals whose social anxiety is “restricted to 
speaking or performing in public” (www.dsm5.org). Alternative classification systems 
currently under consideration include performance versus interactional (or mixed), and 
performance versus observational versus interactional. Another alternative being 
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considered for DSM-V is to provide an updated definition (to be determined) for the 
generalized subtype. The finalized version of the DSM-V is expected to be released in 
2013 (www.dsm5.org).  
Using cluster analysis of the Liebowitz Social Anxiety Scale (LSAS; Liebowitz, 
1987) from several social phobia treatment studies, Eng and colleagues (2000) identified 
three subgroups of social phobia: Pervasive Social Anxiety, Moderate Social Interaction 
Anxiety, and Dominant Public Speaking Anxiety. The Dominant Public Speaking group 
averaged an older age of onset and older age at intake than the Pervasive group. Also, 
individuals in the Dominant Public Speaking group had fewer depressive symptoms, less 
general anxiety, and were less likely to have a comorbid mood disorder or Avoidant 
Personality Disorder. Notably, individuals in all three groups reported public speaking 
anxiety, suggesting the pervasive nature of this fear across those suffering from social 
phobia (Eng et al., 2000). 
 More recently, large-scale community studies (e.g., Ruscio et al., 2008; Vriends et 
al., 2007) have found support for a continuum model of social anxiety, rather than 
discrete subtypes. For example, Ruscio and colleagues (2008) report results from the 
United States National Comorbidity Survey Replication (NCS-R), and conclude that 
social anxiety exists on a continuum based on the number of situations feared. Public 
speaking was the most common social fear, reported by 21.2% of the total sample. Those 
who had a greater number of feared situations were found to have an earlier age of onset 
of social anxiety, more avoidance, lower rates of recovery, higher rates of comorbidity, 
greater impairment, and were less likely to receive treatment for their social anxiety. Due 
to the linear nature of these correlations, Ruscio and colleagues conclude that social 
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anxiety exists on a continuum, and that theoretical distinctions based on the type of 
feared situations (e.g., Hook & Valentiner, 2002; Turner et al., 1992) offer little 
additional information and in fact can be misleading. 
Vriends and colleagues (2007) also found evidence for a continuum of anxiety 
severity related to the number of situations feared, without a clear-cut delineation 
between groups. However, the authors did report a differentiation between those with 
only public speaking fears and those who also had additional fears; the latter group had 
higher rates of comorbidity, a greater subjective need for therapy, more functional 
impairment, and more dysfunctional attitudes (Vriends et al., 2007). Although these 
researchers ultimately argue for a continuum model, it is important to note this distinction 
between public speaking anxiety and more pervasive social phobia. 
 In studies that have employed exposure tasks, such as a behavioral assessment test 
(BAT), individuals have shown different patterns of behavioral and physiological 
responses depending on whether or not their social anxiety was generalized. When 
confronted with a speech performance task, those with nongeneralized social phobia tend 
to show a sharp increase in heart rate at the beginning of the task, whereas people with 
generalized social anxiety experience a more gradual rise in heart rate and have a slower 
return to baseline heart rate (Heimberg, Hope, Dodge, & Becker, 1990; Hofmann, 
Newman, Ehlers, & Roth, 1995; A. P. Levin et al., 1993). Interestingly, when performing 
a social interaction task, this physiological response pattern in individuals with 
nongeneralized social phobia has not been shown; instead, generalized and 
nongeneralized groups have displayed similar patterns of arousal (Boone et al., 1999). 
Given that the nongeneralized subtype of social anxiety typically includes (and often 
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consists solely of) public speaking phobics, the disparate responses between generalized 
and nongeneralized social phobics to a speech task provide empirical support for a 
distinction between generalized social anxiety and primary public speaking anxiety. 
 Although there is considerable variability in the ways in which social anxiety has 
been classified, research generally shows at least some distinction between more and less 
generalized social phobia. On the more circumscribed end of the spectrum are people 
with limited, more performance-oriented fears (most commonly, public speaking 
anxiety), whereas generalized social phobics tend to have higher rates of comorbidity and 
fear a greater variety of situations, including social interactions. Whether social anxiety is 
categorized according to discrete subtypes, or is viewed as a continuum, it seems clear 
that, at the very least, several quantitative and qualitative differences exist between highly 
generalized, pervasive social anxiety and the most circumscribed public speaking phobia.  
 The evidence reviewed herein supports the examination of public speaking 
anxiety as an entity separate from generalized social phobia. The proposed study will 
focus only on the public speaking phobia subtype of SAD. 
1.2. Public Speaking Anxiety 
 Several terms have been used to describe public speaking anxiety, including 
“speech anxiety,” “stage fright,” “audience anxiety,” and the somewhat broader term 
“communication apprehension” (Fremouw & Breitenstein, 1990). In addition to being the 
most commonly feared situation among individuals with social phobia (Ruscio et al., 
2008), a significant portion of the general population experiences public speaking 
anxiety. Community studies have reported prevalence rates ranging from 20% (e.g., 
Pollard & Henderson, 1988) to 34% (M. B. Stein, Walker, & Forde, 1996); some authors 
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estimate that up to 85% of the population experiences at least some level of anxiety in 
public speaking situations (e.g., Motley, 1995). Public speaking fears have been found to 
be associated with lower incomes, higher rates of unemployment, and reduced likelihood 
of postsecondary education; approximately 10% of a community sample reported 
significant distress or interference with work, education, or social life as a result of 
substantial public speaking fears (M. B. Stein et al., 1996). Thus, although discrete public 
speaking phobia is typically less severe than generalized social anxiety (e.g., Vriends et 
al., 2007), it is clearly a substantial problem that often requires clinical intervention. 
1.3. Treatment of Social Anxiety Disorder 
 Although many of the interventions for SAD have been used primarily to treat the 
generalized subtype, the same basic principles apply to the treatment of specific SAD, 
including public speaking anxiety. In fact, many of the treatment studies, particularly 
analogue investigations, have utilized speech-phobic samples. Therefore, the treatments 
discussed below are generally applicable to both generalized SAD and public speaking 
anxiety. Differential treatment effects are discussed where applicable.   
 1.3.1. Pharmacological treatment. A variety of medications have been used in the 
treatment of SAD. These include monoamine oxidase inhibitors (MAOIs), 
benzodiazepines, and beta-blockers (Scholing & Emmelkamp, 1990), as well as 
antiepileptic drugs, including gabapentin (Pande et al., 1999) and pregabalin (Pande et 
al., 2004). More recently, selective serotonin reuptake inhibitors (SSRIs) have been 
shown to be efficacious in treating SAD (see Hedges, Brown, Shwalb, Godfrey, & 
Larcher, 2007, for a recent meta-analysis). A number of SSRIs, including sertraline 
(Zoloft) and paroxetine (Paxil), and one serotonin-noradrenaline reuptake inhibitor 
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(SNRI), venlafaxine (Effexor XR), are currently approved by the U.S. Food and Drug 
Administration (FDA) for the treatment of SAD (Muller, Koen, Seedat, & Stein, 2005). 
Most recently, the extended-release formula of the SSRI fluvoxamine (Luvox CR) 
received approval (FDA, 2008). A recent meta-analysis (Blanco et al., 2003) found that 
phenelzine produced the largest effect sizes on social anxiety outcome measures relative 
to drug placebo (overall effect size = 1.02), but found no significant differences between 
phenelzine and the other drugs included in the studies (e.g., gabapentin, clonazepam, 
brofaromine, and various SSRIs). Recent studies suggest that escitalopram (Lexapro) is 
superior to placebo in preventing relapse in individuals with SAD (Stein, Bandelow, 
Dolberg, Andersen, & Baldwin, 2009). Due in part to their reduced side-effect profile, 
SSRIs are currently recommended as a first-line pharmacological treatment for SAD 
(Bandelow, Zohar, Hollander, Kasper, & Möller, 2002). There is also evidence that beta-
blockers produce a temporary reduction in anxiety symptoms in discrete performance 
situations, including public speaking (e.g., Hartley, Ungapen, Davie, & Spencer, 1983).  
Despite the efficacy of pharmacological treatments, many individuals would 
prefer not to use medication, due to unwanted side effects, concerns about physical 
dependence, or risk of relapse. A number of placebo-controlled drug studies have shown 
high rates of relapse following discontinuation of medications, including SSRIs such as 
paroxetine (D. J. Stein, Versiani, Hair, & Kumar, 2002) and sertraline (Walker et al., 
2000). Several medications for SAD, including the MAOIs phenelzine (Liebowitz et al., 
1999) and moclobemide (Prasko et al., 2003) and the benzodiazepine alprazolam 
(Gelernter et al., 1991), have shown significantly higher rates of relapse compared to 
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cognitive-behavioral treatment. Therefore, although promising, pharmacological 
treatment is not optimal for all individuals with SAD. 
 1.3.2. Psychodynamic treatments. Although psychodynamic interventions have 
been used to treat social anxiety in clinical settings, very little controlled research has 
been reported on psychodynamic therapy for SAD. Claims of its efficacy are found 
primarily in case studies (e.g., Zerbe, 1994) and treatment manuals (e.g., Leichsenring, 
Beutel, & Leibing, 2007). An outcome trial of psychodynamic therapy for SAD revealed 
no differences between psychodynamic group therapy and a credible placebo treatment 
(Knijnik, Kapczinski, Chachamovich, Margis, & Eizirik, 2004). Therefore, 
psychodynamic therapy is not currently scientifically supported in the treatment of SAD 
and public speaking anxiety.  
1.3.3. Relaxation training and systematic desensitization. An early treatment for 
SAD was systematic desensitization, a technique involving muscle relaxation while 
imagining feared stimuli (Wolpe, 1958, 1973). Based on the theory of reciprocal 
inhibition (Sherrington, 1906), the act of relaxing one’s muscles was thought to be 
incompatible with an anxiety response, thus preventing the latter from occurring in the 
imagined presence of phobic cues (Wolpe, 1958). Other forms of relaxation training, 
including progressive muscle relaxation (Bernstein & Borkovec, 1973; Jacobson, 1938) 
and cue-controlled relaxation (Lent, Russell, & Zamostny, 1981), have been used 
specifically to treat public speaking anxiety. However, Wolpe’s (1958) claim that 
desensitization reduces anxiety via reciprocal inhibition has been disputed (e.g., Kirsch & 
Henry, 1977). Although results have been inconsistent, many studies of animal phobias 
have found no added benefit of relaxation over exposure alone (see R. B. Levin & Gross, 
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1985, for a review). Research using socially anxious individuals has also tended to 
suggest that exposure, rather than relaxation, is the crucial component of desensitization. 
For example, in a study utilizing speech-phobic college students, Osberg (1981) found 
that applied relaxation (i.e., relaxation during in vivo exposure) produced greater 
improvement than relaxation alone on self-report and behavioral measures at post-
treatment. A study of females reporting anxiety in opposite-sex interactions (O’Brien & 
Borkovec, 1977) found no differences on behavioral or self-report measures of anxiety 
between systematic desensitization, non-contiguous exposure and relaxation, and 
exposure alone (but see Borkovec & Sides, 1979, for a contradictory result in speech 
phobics). A more recent study failed to demonstrate superiority of systematic 
desensitization over a credible attention placebo in reducing self-reported public speaking 
anxiety (Duff, Levine, Beatty, Woolbright, & Park, 2007). Despite variability in the 
results, the research strongly suggests that exposure is responsible for the efficacy of 
systematic desensitization in the treatment of social anxiety.   
1.3.4. Cognitive treatments. Cognitive therapy (CT) treatments for SAD target the 
cognitive factors (e.g., negative thoughts and beliefs about one’s ability to perform in 
social situations) that are believed to contribute to social anxiety, while simultaneously 
reducing behavioral avoidance via exposure to actual and simulated social situations 
(Hope, Heimberg, & Bruch, 1995). Cognitive-behavioral group therapy (CBGT; 
Heimberg, 1991; Heimberg & Becker, 2002) is the most thoroughly researched treatment 
for SAD (see Turk et al., 2001). CBGT integrates simulated (role-played) exposure to 
feared situations, cognitive restructuring, and homework assignments consisting of in 
vivo exposure (Heimberg & Becker, 2002). CBGT provides a cognitively-based context 
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for exposure, based on the rationale that exposure to feared stimuli will allow clients to 
modify their irrational thoughts (e.g., beliefs regarding catastrophic outcomes in feared 
situations). CBGT has been shown to be more effective than a credible placebo treatment 
(Heimberg, Dodge, et al., 1990), and roughly equivalent to phenelzine treatment 
(although phenelzine produced superior outcomes on some measures; Heimberg et al., 
1998). Comprehensive Cognitive Behavioral Therapy, a variation of CBGT, has been 
shown to be equivalent to fluoxetine in the treatment of generalized SAD (J. R. T. 
Davidson et al., 2004). In the treatment of performance anxiety, CBGT has been found 
superior to buspirone (D. B. Clark & Agras, 1991). Treatment gains for CBGT have been 
maintained at 5-year follow-up (Heimberg, Salzman, Holt, & Blendell, 1993; Nolan, 
2005).  
 D. M. Clark (1997) developed a version of CT based upon D. M. Clark and 
Wells’ (1995) cognitive model of SAD, which focuses on factors that maintain anxiety in 
social situations. According to this theory, SAD is maintained through four processes: 
heightened self-focused attention and monitoring, use of misleading internal information 
resulting in negative inferences regarding self-presentation, excessive use of safety 
behaviors, and negatively biased anticipatory and post-event processing. D. M. Clark’s 
(1997) treatment consists of interventions designed to reverse these maintenance 
processes. Studies have shown CT to be superior to exposure plus fluoxetine (D. M. 
Clark et al., 2003) and exposure with applied relaxation (D. M. Clark et al., 2006).  
1.3.5. Other treatments. A number of other treatments, including flooding, social 
skills training, and virtual reality, have been utilized in the treatment of public speaking 
anxiety. Flooding (as well as its psychodynamic variant, implosive therapy) involves 
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exposing a client, either in vivo or imaginally, to high levels of an anxiety-provoking 
stimulus while simultaneously preventing behavioral avoidance, and has demonstrated 
some efficacy in the treatment of speech anxiety (see Fremouw & Breitenstein, 1990, for 
a brief review). Social skills training, while adding to the efficacy of exposure-based 
treatments for social anxiety (e.g., Herbert et al., 2005), is generally not supported as a 
stand-alone treatment for public speaking anxiety (see Ponniah & Hollon, 2008). 
Recently, virtual reality-based exposure (Anderson, Rothbaum, & Hodges, 2003; 
Anderson, Zimand, Schmertz, & Ferrer, 2007) and internet-based exposure to real 
audiences (Botella et al., 2007) have shown preliminary but promising evidence for the 
treatment of public speaking anxiety. Internet-based self-help programs have been found 
to produce results comparable with those of live therapist-delivered treatment, and have 
been found generally acceptable to patients (Botella et al., 2009). Online treatment has 
been shown not only to improve SAD outcomes, but also to reduce comorbid symptoms 
of depression and GAD (Titov, Andrews, Johnston, Schwencke, & Choi, 2009; Titov, 
Gibson, Andrews, & McEvoy, 2009). CBT delivered via the internet has demonstrated 
superior results for the treatment of SAD compared to wait-list control (Berger, Hohl, & 
Caspar, 2009). Treatment gains for internet-based CBT for SAD have been maintained at 
30-month follow-up (Carlbring, Nordgren, Furmark, & Andersson, 2009).  
 1.3.6. Summary of treatments for SAD/public speaking anxiety. Most of the 
empirically supported, non-pharmacological treatments for public speaking anxiety (as 
well as generalized SAD) highlight exposure as the central active treatment component. 
Typical formats include imaginal exposure, virtual reality, and most commonly, in 
vivo/simulated exposure. Although other elements of treatment (e.g., cognitive 
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restructuring, muscle relaxation) vary across therapies, exposure has consistently been 
held to be a critical ingredient in treating public speaking anxiety.  
1.4. Exposure 
Over the past few decades, in vivo exposure, in which the phobic individual 
confronts the feared stimulus or situation directly, has become prevalent in the treatment 
of various anxiety disorders, including SAD (see Hofmann, 2008). Although other forms 
of exposure exist, such as imaginal and virtual reality exposure (see Wolitzky-Taylor, 
Horowitz, Powers, & Telch, 2008, for a review), in vivo exposure remains an extensively 
utilized component of social phobia treatment research (Ponniah & Hollon, 2008). In 
cognitive-behavioral interventions for SAD/public speaking anxiety, simulated in vivo 
exposure exercises (i.e., role-playing) are a mainstay of treatment (e.g., Herbert & 
Cardiaciotto, 2005; Heimberg & Becker, 2002). 
1.4.1. Mechanisms of action. Understanding of the mechanisms by which 
exposure exerts its effects has evolved in recent years. Originally, it was believed that 
habituation (i.e., a decrease in anxiety response following repeated exposure to a feared 
stimulus; Marks & Tobena, 1990) occurred because repeated presentation of the feared 
object or situation (conditioned stimulus) without the feared outcome (unconditioned 
stimulus) led to an unlearning of the anxiety response (Mowrer, 1939). However, more 
recent evidence from both animals and humans suggests that the extinction of the anxiety 
response occurs as a result of new learning that suppresses that response (see Hofmann, 
2008, and Zlomke & Davis, in press, for reviews of this research). 
1.4.2. Clinical application issues. A key issue in the use of exposure-based 
treatments is the schedule according to which they are delivered, including the number 
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and spacing of sessions. A single-session treatment for specific phobia, relying heavily on 
exposure, was developed by Öst (e.g., 1989; see Zlomke & Davis, 2008, for a review of 
single-session treatments for specific phobias). Conflicting results have been obtained for 
the relative efficacy of massed (often single-session) versus spaced exposure. Rowe and 
Craske (1998) compared massed and expanding-spaced (i.e., increasing intervals between 
sessions) exposure schedules for spider phobia. Whereas the massed exposure group 
demonstrated a greater decrease in fear at post-treatment, the expanding-spaced schedule 
was more effective in preventing the reemergence of phobic symptoms at follow-up. In a 
comparison of massed, uniform- (i.e., evenly spaced) and expanding-spaced exposure 
schedules for the treatment of public speaking anxiety, Tsao and Craske (2000) found a 
similar differentiation between massed exposure (which resulted in a return of fear by 
follow-up) and uniform- and expanding-spaced schedules (in which fear reduction was 
maintained at follow-up). In contrast, Chambless (1990) obtained comparable results for 
daily versus weekly exposure sessions in the treatment of specific phobia and 
agoraphobia. In a trial of cognitive-behavioral group therapy for social anxiety, Herbert, 
Rheingold, Gaudiano, and Myers (2004) found that extending 12 sessions over a total of 
18 weeks produced no additional benefit over holding the sessions over 12 consecutive 
weeks. Chaplin and Levine (1981) found that continuous exposure for 50 minutes was 
more effective in the treatment of public speaking anxiety than were shorter sessions 
divided by a brief interval.  
Social anxiety treatment outcome trials incorporating exposure treatment typically 
range from 4 (Block & Wulfert, 2000) to 20 sessions, with a mean of 12 sessions, usually 
spaced at uniform, 1-week intervals (see Ponniah & Hollon, 2008, for a review). Herbert, 
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Rheingold, and Goldstein (2002) utilized a 6-week treatment for social anxiety and found 
effect sizes comparable to those obtained in studies of 12-week protocols. Taken 
together, these studies suggest that anywhere from 4 to 12 sessions, spaced at 1-week 
intervals, are potentially effective in the treatment of public speaking phobia.  
1.5. Exposure in the Treatment of SAD/Public Speaking Anxiety 
As described above, effective treatments for public speaking anxiety usually 
involve exposure. Typical formats of exposure in the treatment of public speaking 
anxiety include virtual reality and in vivo exposure, including simulated exposure 
exercises. Given that exposure is such a powerful treatment, it is unclear whether the 
context, or framework, in which exposure is conducted has a significant impact on 
treatment outcome. The context or framework may include a rationale for exposure, 
exercises or techniques to help facilitate the practice of exposure, and/or guidelines for 
interpreting one’s experiences after engaging in exposure tasks. The following sections 
will review the research on component studies and context for exposure. 
1.5.1. Component studies of exposure-based treatments. Although SAD/speech 
anxiety treatments incorporating exposure (especially in vivo, often simulated) have 
generally outperformed those that lacked an exposure element, conflicting evidence 
exists regarding whether adding other components to exposure produces additional 
benefit over exposure alone (Ponniah & Hollon, 2008; Turk et al., 2001). Studies of other 
treatment components in combination with exposure have yielded mixed results. Social 
skills training has been found to add to the effectiveness of CBGT (which has an 
exposure component) in treating generalized SAD (Herbert et al., 2005). However, 
another study found that a combination of social skills training, rational emotive therapy, 
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and in vivo exposure was no more effective in treating social anxiety than was exposure 
alone (Mersch, 1995). In a dismantling study of Eye Movement Desensitization and 
Reprocessing (EMDR), the eye-movement component of the treatment produced no 
added benefit over the exposure component in the treatment of public speaking anxiety 
(Carrigan & Levis, 1999; P. Davidson & Parker, 2001; Herbert et al., 2000). Results for 
medications in combination with exposure have also varied. Intranasal oxytocin in 
combination with exposure has been shown to improve positive self-evaluations of 
appearance and speech performance relative to exposure-plus-placebo; however, no 
additional benefit has been found for oxytocin over placebo with respect to SAD 
symptom reduction or overall treatment outcome (Guastella, Howard, Dadds, Mitchell, & 
Carson, 2009). Both D-cycloserine (Hofmann et al., 2006) and sertraline (Blomhoff et al., 
2001; Haug et al., 2000) have been found to enhance the effects of exposure in treating 
SAD in the short term. However, whereas D-cycloserine plus exposure continued to 
outperform exposure alone 1 month after treatment (Guastella et al., 2008), participants 
in a sertraline-plus-exposure condition deteriorated significantly compared to exposure 
alone at long-term follow-up (Haug et al., 2003). D-cycloserine is hypothesized to work 
by strengthening biochemical pathways of learning, thereby facilitating the new learning 
that takes place as a result of exposure (see Hofmann et al.). Therefore, the fact that D-
cycloserine is one of the few interventions that has clearly shown increased efficacy in 
combination with exposure supports the notion that exposure is the key active component 
of treatment for SAD. 
CBGT has demonstrated efficacy in the treatment of both generalized and 
nongeneralized SAD (Hope, Herbert, & White, 1995); however, it is unclear whether the 
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cognitive element of the treatment adds any benefit over the exposure component. For 
example, a dismantling study of CBGT for social phobia revealed few significant 
differences between CBGT and exposure alone, and also found that cognitive changes 
were marginally more extensive in the exposure-only group (Hope, Heimberg, et al., 
1995). Meta-analyses by Gould, Buckminster, Pollack, Otto, and Yap (1997) and Feske 
and Chambless (1995) found no significant differences between exposure alone and 
exposure plus cognitive restructuring. In Taylor’s (1996) meta-analysis, cognitive 
restructuring plus exposure was the only treatment combination that produced significant 
effects over placebo; however, effect sizes for combined treatments did not differ 
significantly from those obtained for exposure alone. Emmelkamp, Mersch, Vissia, and 
van der Helm (1985) found exposure alone to be as effective as two cognitively-based 
interventions: rational-emotive therapy and self-instruction. Several more recent studies 
(Hofmann, 2004; Salaberria & Echeburua, 1998; Scholing & Emmelkamp, 1996) have 
also failed to demonstrate increased benefit with the addition of cognitive interventions to 
exposure. Conversely, two older studies did provide some support to the notion that 
cognitive interventions may produce incremental benefits to exposure alone. Mattick and 
Peters (1988) found that a combined exposure and cognitive restructuring treatment led to 
more improved functioning and a greater decrease in behavioral avoidance relative to 
exposure without cognitive restructuring. Similarly, Butler, Cullington, Munby, Amies, 
and Gelder (1984) found exposure plus cognitively-based anxiety management to be 
more effective than exposure alone in reducing social anxiety. Due to the mixed results 
from this research, it is unclear to what extent adding additional components (such as 
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cognitive restructuring, social skills training, and medication) to exposure produces 
benefit beyond exposure alone in the treatment of SAD/public speaking anxiety.  
1.5.2. Presentation context of exposure. Although the incremental benefit of 
adding other components to exposure is uncertain and perhaps even dubious, it is difficult 
for exposure to be presented in the absence of any context whatsoever. In clinical practice 
as well as in research, exposure is generally presented with some type of rationale, 
usually either a habituation model of anxiety reduction (e.g., Salkovskis, Clark, 
Hackmann, Wells, & Gelder, 1999) or a cognitive modification model (e.g., Hope, 
Heimberg, et al., 1995). There is evidence that the way in which exposure is framed can 
affect treatment outcome. In a landmark study, Southworth and Kirsch (1988) led 
agoraphobic individuals to believe that they were participating in exposure either for the 
purpose of therapy (high expectancy) or for the purpose of obtaining a baseline 
assessment of their anxiety levels (low expectancy). In reality, the treatments (10 
individual sessions of exposure over a 2-3 week period) were identical across the high 
and low expectancy conditions. Results revealed greater pre-to-post-treatment 
improvement on behavioral measures for the high expectancy (“treatment”) than for the 
low expectancy (“assessment”) group, and the latter did not differ significantly from a 
no-treatment control group on measures of behavioral change. This study indicates that 
the context in which exposure is presented can produce a substantial impact on treatment 
outcome. 
Prior to the popularization of CBT, exposure was typically presented according to 
a habituation model (i.e., prolonged and/or repeated contact with a feared stimulus should 
lead to a reduction in anxiety; Lader & Mathews, 1968). More recently, a cognitive 
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change rationale is often provided (e.g., Heimberg & Becker, 2002). Evidence for the 
relative efficacy of the habituation model compared to the cognitive restructuring model 
has been inconclusive. In a small pilot study (n=16) of individuals suffering from panic 
disorder and agoraphobia, a cognitive model of exposure produced greater improvement 
on self-report and behavioral measures of anxiety, panic, and avoidance than did 
exposure presented within a habituation context (Salkovskis, Hackmann, Wells, Gelder, 
& Clark, 2007). Importantly, the rationales presented for the two conditions in this study 
were roughly equivalent in terms of length and detail in order to reduce the likelihood 
that the two conditions would produce unequal expectancies for improvement. However, 
although the difference between the credibility ratings for the two conditions was not 
statistically significant, the cognitive change condition’s credibility was rated almost an 
entire standard deviation above that of the habituation condition. With a larger sample 
size, this difference would likely have reached statistical significance. Thus, due to the 
possibility of differential expectancies, it is difficult to make conclusions regarding the 
relative efficacy of CBT and habituation rationales for exposure based on this study. 
Habituation has also been used as a context for exposure in a control condition. 
For example, in a dismantling study of CBGT for SAD, Hope, Heimberg, and colleagues 
(1995) presented their exposure-only group with an explanation of classical conditioning 
and habituation as a context for exposure. To control for time devoted in the CBGT 
condition to cognitive restructuring, participants in the exposure-only group were taught 
attention control procedures, spent time graphing subjective anxiety ratings, and were 
instructed to identify environmental anxiety triggers. Thus, “exposure alone” generally 
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refers to exposure with some general form of rationale or context, although studies vary 
in the degree to which this context is emphasized.  
Typically, cognitively-based exposure therapies (e.g., CBGT; Heimberg & 
Becker, 2002) frame exposure as an opportunity to challenge dysfunctional cognitions 
(e.g., the belief that negative outcome will result from exposure to feared stimuli), and as 
a chance to experience the (eventual) reduction of anxiety in feared situations. Although 
not always explicitly stated, cognitively-based treatments (e.g., Heimberg & Becker) 
have utilized a form of distancing, or separation, between the client and his or her 
thoughts and feelings. The process of cognitive restructuring allows clients to “step back” 
from their thoughts and examine them objectively, creating distance between the client 
and his or her cognitions (see Beck, 1995). However, because this distancing is not a 
primary focus in traditional cognitively-based exposure, it is not typically mentioned in 
the rationale or accompanying exercises for exposure tasks (e.g., Heimberg & Becker). 
The so-called “third generation” behavior therapies, such as Acceptance and 
Commitment Therapy (ACT), explicitly identify the creation of distance between oneself 
and one’s cognitions as a goal of therapy (Herbert, Forman, & England, 2009). These 
approaches emphasize acceptance of, rather than control over, private experiences (e.g., 
anxiety), in the context of pursuing value-driven goals (Hayes, Strosahl, & Wilson, 
1999). In acceptance-based therapies, exposure is often used as a tool for increasing one’s 
willingness to experience anxiety (rather than as a method for altering one’s cognitions or 
reducing anxiety, as in CBGT). In ACT, exposure is framed as an opportunity to 
participate in valued actions while accepting and distancing oneself from feelings and 
cognitions (Orsillo, Roemer, Block-Lerner, LeJeune, & Herbert, 2004). In addition, 
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exposure in ACT is viewed as an additive process; unlike exposure in traditional CBT, 
which aims to reduce anxiety symptoms, the goal of exposure in ACT is to increase 
valued behavior (Hayes & Duckworth, 2006). The key processes involved in exposure 
from an ACT perspective are cognitive defusion, or separation from one’s thoughts and 
feelings of anxiety, and acceptance of these private cognitive and affective experiences. 
1.6. Exposure in the Context of Cognitive Defusion and Acceptance 
One of the core components of ACT is “cognitive defusion,” or detachment, from 
one’s thoughts, feelings, and experiences. According to the ACT model, if one is defused 
from his or her thoughts and feelings, it means that one can achieve distance from them 
and see them merely as mental events, rather than seeing them as part of the self. For 
example, a person who is highly fused with his or her anxiety might have the thought “I 
am anxious,” whereas a person who is defused from that feeling may think “I am having 
the feeling of anxiety.” According to ACT, being excessively “fused” with one’s private 
experiences can lead to distress, whereas cognitive defusion should be associated with 
psychological flexibility, positive mental health, and better overall functioning (Hayes, 
Strosahl, et al., 1999).  
Defusion is arguably not an entirely new idea; related constructs such as 
metacognitive awareness and cognitive distancing show many similarities to defusion. 
Metacognition, as originally defined by Flavell (1976, p. 232), refers to “one’s 
knowledge concerning one’s own cognitive processes or anything related to them.” 
Metacognition, or metacognitive awareness, has been used largely to refer to the 
understanding of knowledge and of one’s own learning processes (e.g., Jacobs, 2004; 
Vandergrift, 2005). In their research with depressed populations, Teasdale and colleagues 
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have used the term “metacognitive awareness” to mean “a cognitive set in which negative 
thoughts/feelings are experienced as mental events, rather than as the self” (Teasdale et 
al., 2002, p. 275). Furthermore, in contrast to traditional notions of “distancing” or 
“decentering” (Teasdale, Segal, & Williams, 1995) from one’s thoughts and feelings as a 
means of changing cognitions as used in traditional cognitive therapy (e.g., Beck, 1995), 
Teasdale and colleagues (2002) use metacognitive awareness to refer to the idea of such 
distancing for the purpose of changing one’s relationship to one’s private cognitions, 
rather than trying to change the cognitions themselves. This definition is very similar, if 
not identical, to defusion. However, metacognitive awareness has been used mainly in 
relation to cognitive therapy for depression (e.g., Segal, Williams, & Teasdale, 2002), 
whereas defusion has been applied more broadly (see Hayes & Strosahl, 2004).  
 Although research into the effects of defusion and related constructs is still in its 
early stages, several studies exist comparing the relative effectiveness of control-based 
versus acceptance-based coping strategies (see Hayes, Luoma, Bond, Masuda, & Lillis, 
2006, for a review). These studies tend to incorporate defusion (e.g., from feelings of 
pain) into their acceptance-based interventions. Analogue pain experiments using the 
cold-pressor task (e.g., Hayes, Bissett, et al., 1999; Keogh, Bond, Hanmer, & Tilston, 
2005) and shock (Gutierrez, Luciano, Rodriguez, & Fink, 2004; McMullen et al., in 
press) have generally found the acceptance-based interventions to be more effective than 
control-based strategies. Control- and acceptance-based strategies have also been 
compared with respect to coping with negative thoughts (Masuda, Hayes, Sackett, & 
Twohig, 2004) and food cravings (Forman et al., 2007). Control-based strategies used in 
the analogue studies have included positive self-talk, controlled breathing, positive 
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imagery, distraction, and body focusing, whereas acceptance-based strategies have 
included instructions to “disconnect” from the pain or distressing experiences, to allow 
the private experiences to be there without letting them control behavior, and to see them 
as separate from the self (Eifert & Heffner, 2003; Forman et al., 2007; Gutierrez et al., 
2004; Hayes, Bissett, et al., 1999; Keogh et al., 2005; Masuda et al., 2004). Research on 
coping with negative thoughts has utilized a technique in which a thought is repeated 
rapidly until it loses its meaningful associations (Masuda et al.). All of the acceptance-
based strategies used in these analogue studies rely heavily on the idea of defusion. 
1.7. Acceptance-Based Treatment for Social Anxiety 
Currently, published research on ACT for social anxiety is limited. In a pilot 
study of a 12-session, individual-treatment ACT protocol for generalized SAD, 
Dalrymple and Herbert (2007) found that ACT produced significant improvement in 
symptom severity and quality of life, as well as in measures of ACT processes, in a 
clinical sample (n=19). The treatment included exposure to feared social situations based 
on individualized fear hierarchies (see Wolpe, 1958) in sessions 3 through 12. Exposure 
exercises included both simulated role-play tasks and in vivo exposure to actual 
situations. The rationale for exposure was presented from an ACT perspective; exposure 
was framed as a chance to practice one’s willingness to experience anxiety while 
participating in social situations. The protocol also incorporated other elements of ACT, 
including clarification of personal values and mindfulness training (see Hayes, Strosahl, 
et al., 1999). In an uncontrolled pilot study, Ossman, Wilson, Storaasli, and McNeill 
(2006) reported similar results for a 10-session ACT-based group treatment for SAD. 
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Although preliminary, these studies provide preliminary evidence of the efficacy of 
acceptance-based treatment for social anxiety. 
 Very little published research to date has investigated the efficacy of ACT 
specifically for public speaking anxiety. Block and Wulfert (2000) semi-randomly 
assigned an analogue population of undergraduates (n=11) with public speaking anxiety 
to four weekly sessions of group ACT, CBGT, or waitlist control. The ACT condition 
incorporated the concepts of willingness, valued action, and acceptance, and exposure 
was framed as an opportunity just to notice one’s thoughts and feelings, rather than to 
change them. Measures of anxiety tended to decrease, whereas willingness ratings 
increased, in both active treatment conditions relative to placebo; however, the small 
sample size precluded statistical analyses. In an extension of this study incorporating a 
larger sample of undergraduates (n=39) and 6 weeks of treatment, only the ACT group 
displayed a significantly greater increase in speech length (i.e., decreased behavioral 
avoidance) relative to no-treatment control, although both active treatment groups 
showed decreased anxiety and increased willingness (Block, 2003). 
 Thus far, no component control studies have attempted to augment exposure with 
an acceptance/defusion rationale. Additionally, there have been no studies of ACT 
processes in the treatment of a clinical population with public speaking anxiety. Given 
the varied results of the research on adding components to and modifying the context of 
exposure, it is unclear whether an acceptance/defusion context for exposure will produce 
additional benefit beyond exposure with a habituation-based rationale. However, the 
encouraging results obtained thus far in studies of acceptance-based therapy for social 
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anxiety and public speaking suggest that this is a logical next step in the treatment 
validation process. 
1.8. Current Study: Rationale, Design, and Hypotheses 
 The primary aim of the current study was to examine the efficacy of an 
acceptance/defusion framework for exposure in a clinical population of individuals with 
public speaking anxiety, relative to a standard habituation rationale for exposure. The 
present study compared the efficacy of exposure within the context of acceptance and 
defusion (ACT) relative to exposure with a habituation rationale (HAB) for the treatment 
of public speaking anxiety. This study utilized a clinical sample whose public speaking 
anxiety met DSM-IV-TR criteria for nongeneralized (i.e., specific) SAD. Participants 
were assessed at baseline, pre-treatment, mid-treatment, post-treatment, and 6-week 
follow-up; participants also completed a brief weekly assessment of functioning. 
Treatment was administered in a group format consisting of 6 weekly sessions. The 
design of the study was a 2 (condition) by 4 (assessment occasion) mixed factorial 
design. 
 The following hypotheses were offered. 
1. Given the promising results obtained for acceptance-based treatment of social 
anxiety/public speaking anxiety thus far, it was hypothesized that participants 
in the ACT condition would experience a greater reduction in anxiety and 
behavioral avoidance, and greater improvement in measures of quality of life, 
compared to participants in the HAB condition, at post-treatment and follow-
up.  
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2. Additionally, due to the encouraging results of research targeting ACT’s 
component processes, it was expected that acceptance, defusion, and 
mindfulness would mediate treatment outcome. Specifically, greater changes 
on measures of these three constructs were expected to account for a 
significant portion of the effect of treatment condition on the dependent 
variables.  
3. Consistent with ACT’s conceptualization, it was hypothesized that lower 
baseline levels of public speaking anxiety and overall anxiety would be 
associated with higher baseline quality of life, mindfulness, acceptance, 
defusion, and social skills.  
4. Baseline levels of acceptance, defusion, and mindfulness were expected to 
predict overall treatment response, regardless of intervention condition. 
5. It was hypothesized that participants in the ACT condition would engage in 
more between-session exposure (i.e., homework assignments) than would 
participants in the HAB condition. 
6. It was further expected that amount of exposure would mediate the 
relationship between treatment condition and outcome. Specifically, it was 
hypothesized that the amount of time spent engaging in exposure exercises 
outside of sessions would account for a significant portion of the effect of 
treatment condition on outcome. 
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CHAPTER 2: METHODS 
2.1. Participants 
The current study was conducted using a clinical sample of individuals with 
public speaking anxiety. Participants were recruited from the Greater Philadelphia area. 
The study was publicized via various media outlets, and through flyers posted throughout 
the community. Announcements regarding the study were posted on the website of the 
Drexel University Acceptance-Based Behavior Therapy Program and in other community 
resources (e.g., Craigslist). All announcements directed interested individuals to contact 
the Drexel Social Anxiety Treatment Program, or the project coordinator, by phone or 
email.  
Previous studies of CBT (e.g., Heimberg et al., 1998) and ACT (Dalrymple & 
Herbert, 2007) for the treatment of social anxiety disorder have tended to find large pre-
to-post (and, in the case of CBT, between-treatment) effect sizes in outcome measures. 
According to Cohen’s Power Primer (1992), the present study would require 52 
participants (26 per group) for a 2-group ANOVA, with a power level of .80 and alpha of 
.05, to detect a large effect size. Similarly, SamplePower 2.0 (Statistical Package for the 
Social Sciences, 2000) yields a total of 56 participants for a 2-group ANOVA with the 
same power, alpha, and effect size. In contrast, according to a power analysis conducted 
using G*Power 3 (Faul, Erdfelder, Lang, & Buchner, 2007), only 34 participants (17 per 
group) would be needed to detect a medium effect size (f = .25) with the same power and 
alpha levels for the interaction term of a 2-group, 2-repetition repeated-measures 
ANOVA. It is possible that the G*Power analysis is more accurate, given that it is the 
only model that takes into account the repeated-measures design of the study. Due to 
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limited resources, the study aimed to recruit 40 participants (20 per condition). This goal 
was exceeded (see below).  
 Inclusion criteria included clinically diagnosable public speaking anxiety (per 
DSM-IV-TR criteria for nongeneralized social anxiety disorder), fluency in English, aged 
18-65, and residence in the greater Philadelphia area. Exclusion criteria included 
pervasive developmental disability, acute suicide potential, unwillingness or inability to 
travel to the treatment site, and certain comorbid Axis I diagnoses, namely: generalized 
SAD, schizophrenia or other psychotic disorder, and current substance dependence. 
Comorbid diagnoses of Major Depressive or other mood or anxiety disorders were 
acceptable ONLY if clearly secondary to the diagnosis of public speaking anxiety. 
 Of the 132 individuals who underwent a phone screening, 70 met initial inclusion 
criteria and agreed to participate in the diagnostic interview. Following the interview, 11 
were excluded because they did not meet eligibility criteria, and 1 refused to participate, 
leaving 58 eligible individuals. Of these, 13 dropped out before randomization and were 
excluded from further analyses. Therefore, a total of 45 individuals were randomized (21 
(47%) in the ACT condition, and 24 (53%) in the HAB condition) and attended at least 
one treatment session. Of these, 35 (16 (46%) ACT, 19 (54%) HAB) were considered 
treatment completers. Treatment completion was defined as attendance of at least three 
group sessions, including the last session. Participants who could not attend the final 
session, but who had attended at least three group sessions, were still considered 
completers if they were able to attend a final individual session (in person or via phone) 
and complete at least part of the post-treatment assessment measures.  
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 Of the participants who were enrolled and randomized (n = 45), 36 (80%) were 
female and 9 (20%) were male. The participants’ mean age was 31.93 years (SD = 10.55; 
range = 19-63), and 46.7% of the sample was single (46.7% married or living with 
partner, 4.4% divorced, 2.2% declined to answer). Ethnicity of the sample was as 
follows: 13.3% African American/Black, 8.9% Asian American, 4.4% Asian/Pacific 
Islander, 64.4% White, 2.2% Latino/Hispanic, 4.4% Multiracial, and 2.2% declined to 
answer. The majority of participants (75.6%) were students (22.2% undergraduate, 53.3% 
graduate).  
2.2. Measures 
2.2.1. Diagnostic Measures 
2.2.1.1. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID). The 
SCID (First, Spitzer, Gibbon, & Williams, 1996) is an extensively utilized structured 
diagnostic interview based on DSM-IV (APA, 1994) criteria. Estimates of interrater 
reliability range from moderate to high for most Axis I disorders, including social phobia 
(e.g., Williams et al., 1992; Zanarini & Frankenburg, 2001). In several studies utilizing a 
longitudinal examination of patient data, the SCID has demonstrated superior diagnostic 
validity over other structured clinical interviews at intake (Basco et al., 2000; Fennig, 
Craig, Lavelle, Kovasznay, & Bromet, 1994; Fennig, Naisberg-Fennig, Craig, 
Tanenberg-Karant, & Bromet, 1996; Kranzler et al., 1995; Kranzler, Kadden, Babor, 
Tennen, & Rounsaville, 1996). Dalrymple and Herbert (2007) successfully utilized the 
SCID to identify individuals with generalized social anxiety disorder. According to 
standard SCID procedure, potential participants in the current study were administered 
the initial screening portion of the interview, and only the relevant diagnostic modules as 
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indicated by the screening measure were administered thereafter. All participants were 
administered at least the mood and anxiety disorders modules. 
 2.2.1.2. Anxiety Disorders Interview Schedule (ADIS-IV)—Social Phobia section. 
The ADIS-IV (Brown, DiNardo, & Barlow, 1994) is a diagnostic interview schedule used 
to assess anxiety disorders according to DSM-IV criteria. In the current study, only the 
social phobia portion of the ADIS-IV was used to increase reliability in the diagnosis of 
nongeneralized SAD. Sufficient inter-rater reliability has been found for the ADIS-IV in 
diagnosing SAD, as well as in diagnosing other anxiety disorders (Brown, DiNardo, 
Lehman, & Campbell, 2001). The ADIS-IV has been used in studies of social anxiety 
(e.g., Dalrymple & Herbert, 2007; Newman, Kachin, Zuellig, Constantino, & Cashman-
McGrath, 2003) to improve diagnostic accuracy. 
2.2.2. Outcome Measures 
2.2.2.1. Personal Report of Communication Apprehension (PRCA-24). The 
PRCA-24 (McCroskey, 1982) is a modified version of the original 25-item PRCA 
(McCroskey, 1970). The PRCA-24 consists of 24 self-report items assessing 
communication apprehension in four contexts (6 items per context): group discussions, 
meetings, interpersonal conversations, and public speaking. Items consist of statements to 
be rated on a 5-point Likert-type scale ranging from “Strongly Agree” to “Strongly 
Disagree.” An example item from the public speaking subscale is “My thoughts become 
confused and jumbled when I am giving a speech.” The PRCA-24 has demonstrated high 
internal consistency, criterion validity, and content validity (McCroskey, Beatty, 
Kearney, & Plax, 1985), as well as construct validity (Keaten, Kelly, Begnal, Heller, & 
Walker, 1993) and convergent validity (Keaten & Kelly, 1994). Test-retest reliability is 
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high (Rubin, Graham, & Mignerey, 1990), supporting the use of the PRCA-24 as a trait 
measure of communication apprehension. Factor analysis of the PRCA-24 has revealed 
four distinct dimensions based on the four communication contexts assessed, supporting 
the use of each as an independent factor (Levine & McCroskey, 1990). Several studies 
(Ayers, 1988; Richmond & McCroskey, 1995; Rubin et al., 1990) have found the four 
factors of the PRCA-24 to be distinct from one another. The current study, therefore, 
utilized only the public speaking subscale of the PRCA-24.  
2.2.2.2. Personal Report of Confidence as a Speaker (PRCS)—Short Form. The 
PRCS, a self-report measure of confidence in public speaking situations, was originally 
developed by Gilkinson (1942) and modified by Paul (1966) into a 30-item true/false 
format. The PRCS has been shown to have significant internal consistency and 
convergent validity with several other public speaking measures (Daly, 1978). Hook, 
Smith, and Valentiner (2008) proposed a 12-item version of the PRCS based on their 
analysis of its factor structure. This short form, comprised only of straightforwardly 
worded (i.e., not reverse-worded) items, demonstrated internal consistency and construct 
validity, as well as convergent validity with measures of anxiety, social performance 
anxiety, shyness, and self-consciousness; its correlations with these measures equaled or 
surpassed those of the 30-item version (Hook et al., 2008). The short form also showed 
preliminary evidence of divergent validity with a measure of sociability. Although the 
authors acknowledge that further investigation is necessary, they conclude that the short 
form of the PRCS has shown promise for research and clinical settings as a useful 
measure of public speaking fears.  
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2.2.2.3. Self-Statements During Public Speaking (SSPS). The SSPS (Hofmann & 
DiBartolo, 2000) is a 10-item self-report measure designed to assess cognitions in public 
speaking situations. The SSPS contains two 5-item subscales: Positive Self-Statements 
(SSPS-P) and Negative Self-Statements (SSPS-N). Items are rated on a 6-point Likert 
scale ranging from 0 (do not agree at all) to 5 (agree extremely). Across clinical (social 
phobia) and nonclinical samples, both subscales of the SSPS have shown good internal 
consistency (Hofmann & DiBartolo, 2000; Hofmann, Moscovitch, Kim, & Taylor, 2004) 
and test-retest reliability, as well as convergent and discriminant validity (Hofmann & 
DiBartolo). The SSPS-N, which has been found to correlate significantly with 
psychopathology (Hofmann & DiBartolo), has demonstrated sensitivity to change as a 
result of short-term treatment (Anderson et al., 2003; Hofmann & DiBartolo). 
Additionally, individuals who scored high on the SSPS-N reported greater subjective 
anxiety and greater negative affect during a speech task, as well as lower expectations for 
success prior to and lower satisfaction with their performance after a speech (Hofmann & 
DiBartolo). 
2.2.2.4. State-Trait Anxiety Inventory (STAI)—State Scale. The STAI 
(Spielberger, 1983; Spielberger, Gorsuch, & Lushene, 1970) is a self-report measure 
consisting of two 20-item scales (one measuring state anxiety and one measuring trait 
anxiety). For the current study, only the state scale (A-State) of the STAI was used. The 
A-State instructs respondents to rate, on a 4-point Likert scale ranging from “not at all” to 
“very much so,” how they feel at the present moment. Example items include “I feel 
tense” and “I feel nervous.” The two STAI scales have demonstrated high internal 
consistency (Spielberger, 1989) and adequate convergent and discriminant validity 
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(Spielberger, 1983). Additionally, the A-State has shown sensitivity to changes in anxiety 
over time (Spielberger, 1983), supporting its use as a measure of transitory, situational 
anxiety. The A-State has also been shown to discriminate between respondents who 
completed the measure in stressful versus non-stressful conditions (Metzger, 1976). In a 
study of public speaking anxiety, the A-State has been found to correlate significantly 
and positively with the PRCA (McCroskey & Beatty, 1984). 
2.2.2.5. Quality of Life Inventory (QOLI). The QOLI (Frisch, 1994) is a 32-item 
self-report instrument measuring perceived importance of and satisfaction in 16 life 
domains, such as health, work, community, and friendships. For each domain, 
respondents rate the importance of that area on a 3-point scale ranging from 0 (not 
important) to 2 (extremely important). Respondents also rate their satisfaction in each 
domain on a 6-point scale ranging from -3 (very dissatisfied) to +3 (very satisfied). The 
QOLI has demonstrated high test-retest reliability and high internal consistency across 
clinical and nonclinical samples, as well as good criterion validity (Frisch, Cornell, 
Villanueva, & Retzlaff, 1992). The QOLI has shown good convergent validity with other 
measures of subjective well-being, and correlates significantly and negatively with 
measures of psychopathology, depression, and anxiety (Frisch et al., 1992). In social 
anxiety treatment research, the QOLI has shown sensitivity to treatment effects of an 
internet self-help program (Andersson et al., 2006), CBGT (Safren, Heimberg, Brown, & 
Holle, 1996/1997), and ACT (Dalrymple & Herbert, 2007). 
2.2.2.6. Clinical Global Impression Scale (CGI). The CGI (National Institute of 
Mental Health, 1985) is a clinician-rated measure of global symptom severity and 
improvement. The CGI-Severity (CGI-S) requires the clinician to rate symptom severity 
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on a 7-point scale, ranging from 1 (normal/not at all ill) to 7 (among the most extremely 
ill patients). The CGI-Improvement (CGI-I) asks the clinician to estimate the patient’s 
improvement over baseline, from 1 (very much improved) to 7 (very much worse). An 
early modified version of the CGI for social anxiety has demonstrated good interrater 
reliability (Juster, Heimberg, & Mattia, 1993). In a study of the most recent version of the 
CGI for SAD, the CGI-S was shown to have good convergent validity with self-report 
measures of quality of life, depression, and impairment, and with both self-report and 
clinician-administered measures of social anxiety, across assessment time points (Zaider, 
Heimberg, Fresco, Schneier, & Liebowitz, 2003). The CGI-I demonstrated adequate 
convergent validity with measures of social anxiety symptoms, but not with depression, 
quality of life, or impairment. The CGI-S and CGI-I were also found to correlate highly 
with one another (Zaider et al., 2003). In the current study, an independent evaluator 
completed the CGI-S at baseline, post-treatment, and follow-up, and completed the CGI-I 
at post-treatment and follow-up only. 
2.2.2.7. Behavioral Assessment Test (BAT). At pre- and post-treatment, 
participants completed a brief Behavioral Assessment Test (sometimes referred to as the 
Behavioral Avoidance Test; see McGlynn, 1988) consisting of an impromptu speech 
before a small audience (i.e., graduate-student confederates). Participants were allowed to 
continue speaking for up to 10 minutes (see Beidel, Turner, Jacob, & Cooley, 1989); 
length of speech was recorded as a measure of behavioral avoidance. Prior to beginning 
the BAT, participants were prompted to choose a speech topic randomly by drawing a 
topic from a box. In actuality, each piece of paper in the box listed the same topic: 
“Things to do in the Philadelphia area” (at pre-treatment) and “Description of an ideal 
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vacation” (at post-treatment). The topic was changed from pre- to post-treatment in order 
to reduce practice effects. The experimenter provided the participant with a clip-on 
“STOP” card, which the participant could hold up to indicate when he or she wished to 
stop the speech. In several studies involving extended speech BATs (e.g., Hofmann et al., 
2004; Ries et al., 1998), participants are given the opportunity to use such a visual cue to 
end the speech because they may be too anxious or lack the social skills necessary to 
verbalize their desire to end the task (McNeil, Ries, & Turk, 1995). The following 
instructions regarding exiting the BAT were given prior to initiating the speech: “We 
would like you to continue speaking for as long as you can. If you reach a certain time 
point, I will tell you to stop. If you wish to stop before then, please say ‘I want to stop’ or 
hold up the “STOP” card that I gave you.” Participants were asked to rate their anxiety on 
the Subjective Units of Discomfort Scale (SUDS; Wolpe & Lazarus, 1966), which ranges 
from 0-100, at the beginning of the BAT session (prior to receiving further instructions) 
and again just prior to beginning the actual speech. At the conclusion of the speech, 
participants were asked to give another SUDS rating and also to report their highest 
SUDS level during the entire BAT. All speeches were videotaped. 
The first three minutes (or less, for cases in which the participant failed to speak 
for three full minutes) of each BAT speech were evaluated by an independent assessor 
blind to treatment condition and assessment time point. The three-minute time frame was 
chosen in order to be consistent with previous research on social skills in socially anxious 
populations (i.e., Dalrymple & Herbert, 2007). A second assessor rated 30% of the BAT 
speeches for reliability purposes. The assessors provided ratings of perceived anxiety, 
using the same scale (0-100) that the participants used for their SUDS ratings. Assessors 
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also rated participants’ social skills during the BAT. Using a 5-point Likert scale ranging 
from 1 (Poor) to 5 (Excellent), assessors rated social skills on three dimensions: verbal 
content, nonverbal skills, and paralinguistic skills. Assessors also provided a rating of 
overall social skills, using the same 5-point scale. There is support for the use of social 
skills ratings in role-play tests, including speech tasks (Herbert et al., 2005). Assessors 
were trained to a reliability level of .80. Interrater reliability was monitored using 
intraclass correlations (ICC; see Dalrymple & Herbert, 2007). Final Cronbach’s alpha for 
the ICC was .86. 
2.2.2.8. Between-Session Exposure Exercises. At the end of sessions 2-5, 
participants were assigned public-speaking exposure exercises for homework. 
Participants were asked to record the nature of and amount of time (in minutes) spent in 
each exposure exercise on a worksheet (see Appendix M for worksheets used in the 
treatments). 
2.2.2.9. Demographics Questionnaire. At baseline, participants completed a 
demographics questionnaire on which they reported their age, occupation, marital status, 
ethnicity, education level, and treatment history. 
2.2.3. Mediational/Process Measures 
2.2.3.1. Drexel Defusion Scale (DDS). The DDS (Forman, Herbert, & Moitra, 
2008) is a 10-item self-report measure of cognitive defusion. After reading a 3-paragraph 
definition of defusion, respondents rate (on a 6-point Likert scale ranging from “not at 
all” to “very much”) their ability to defuse from thoughts or feelings in 10 different 
domains, such as anger, anxiety, and thoughts about the future. Each item begins with a 
brief description of the domain to be assessed. An example is the following: “Things 
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have not been going well at school or at your job, and work just keeps piling up.  To what 
extent would you normally be able to defuse from anxious thoughts like ‘I’ll never get 
this done’?” 
The DDS has been piloted with a treatment-seeking population (composed of 
graduate students) in the Drexel University Student Counseling Center, as well as with an 
analogue sample of undergraduates (Forman, Herbert, et al., 2008). The measure was 
found to comprise a single factor, consistent with the unidimensional construct of 
defusion. Internal reliability and inter-item correlations were high. In both the clinical and 
nonclinical samples, the DDS demonstrated good internal consistency (Cronbach’s alpha 
= .80 for the clinical and .83 for the nonclinical sample), as well as convergent validity 
with measures of psychological acceptance and quality of life. The DDS was found to 
correlate significantly and negatively with psychopathology and experiential avoidance. 
In the clinical sample, the DDS demonstrated incremental validity with measures of 
psychopathology and quality of life, after controlling for similar constructs. Though 
preliminary, these results suggest that the DDS is a useful measure of cognitive defusion. 
2.2.3.2. Philadelphia Mindfulness Scale (PHLMS). The PHLMS (Cardaciotto, 
Herbert, Forman, Moitra, & Farrow, 2008) is a 20-item self-report measure designed to 
assess the two key components of mindfulness: moment-to-moment experiential 
awareness and non-judgmental psychological acceptance. Items are rated on a 5-point 
Likert scale ranging from “never” to “very often”. A sample item from the Awareness 
subscale is “I am aware of what thoughts are passing through my mind.” A sample item 
from the Acceptance subscale is “I try to distract myself when I feel unpleasant 
emotions.” The measure was validated using clinical and nonclinical samples, and was 
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able to discriminate between these two populations. Each of the two subscales was found 
to be highly internally consistent (Cronbach’s alpha = .85 and .87 for Awareness and 
Acceptance, respectively); the two subscales were determined to represent independent 
dimensions of mindfulness and were not correlated with one another. Evidence was also 
found for convergent and discriminant validity with measures of well-being and 
psychopathology. The PHLMS has demonstrated adequate concurrent validity with other 
measures of mindfulness, although its bidimensional assessment of mindfulness is unique 
(Cardaciotto et al., 2008). 
2.2.3.3. Acceptance and Action Questionnaire – II (AAQ-II). The AAQ-II (Bond 
et al., 2008) is a 10-item, unidimensional measure of an individual’s ability to accept 
unpleasant internal experiences while continuing to engage in valued behaviors. Items are 
scored on a 7-point Likert scale ranging from “never true” to “always true.” An example 
item is “Worries get in the way of my success.” A higher score on the AAQ-II represents 
greater psychological acceptance. The AAQ-II is a revised version of the original 
Acceptance and Action Questionnaire (AAQ; Hayes et al., 2004). The original AAQ, 
though useful across a number of studies (see Hayes et al., 2006 for a review), 
demonstrated some weaknesses, such as problems with internal consistency, as a result of 
item wording and item selection procedures; these problems were addressed in the 
development of the AAQ-II (Bond et al.) The AAQ and AAQ-II have been found to be 
highly correlated with one another (r = .82). Preliminary evidence gathered from seven 
samples suggests that the AAQ-II possesses adequate concurrent, predictive, convergent, 
discriminative, and incremental validities and test-retest reliability (Bond et al.). The 
authors found that AAQ-II scores were negatively correlated with depression, stress, 
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anxiety, and overall psychological distress, and that AAQ-II scores predicted overall 
distress a year later. Higher scores on the AAQ-II were also found to predict changes in 
functional performance in the workplace, including increased sales and decreased 
absence rates. 
2.2.3.4. Before-Session Questionnaire (BSQ). The BSQ (Forman, Chapman, & 
Herbert, 2008) is a 15-item self-report measure of thoughts and feelings in several 
domains, such as life satisfaction, anxiety, and progress toward one’s goals, during the 
previous week. Items are rated on a 7-point Likert scale. In a study comparing traditional 
CBT and ACT, responses to items on the BSQ were found to mediate treatment response 
and to correlate significantly with measures of depression, anxiety, life satisfaction, 
acceptance, and believability and frequency of distorted thoughts (Forman et al., 2006). 
The BSQ was administered at the beginning of each treatment session. 
2.2.3.5. Reaction to Treatment Questionnaire (RTQ). The RTQ (Holt & 
Heimberg, 1990) is a self-report measure designed to evaluate treatment credibility and 
outcome expectancy. A modified version, specific to public speaking anxiety, was used 
in the current study. The first three items, originally constructed by Borkovec and Nau 
(1972), ask respondents to rate (on a 10-point scale) the general logic and credibility of 
the treatment. A second section contains two items on which participants rate, again on a 
10-point scale, their confidence that the treatment would eliminate fears in anxiety-
provoking social situations (Amies, Gelder, & Shaw, 1983). A final section consists of 
four items asking respondents to rate the current severity, from 1 (not at all severe) to 10 
(very severe), of their main fear, as well as how severe they expect their main fear to be 
at the end of treatment and at one and five years post-treatment. The RTQ has shown 
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high internal consistency and has been found to correlate negatively with various social 
anxiety and functional impairment measures, and to have predictive validity regarding 
treatment outcome (Safren, Heimberg, & Juster, 1997). Participants completed the RTQ 
at the conclusion of the first session, after they had been presented with the treatment 
rationale. 
2.3. Procedure 
 Individuals expressing interest in the study were asked to participate in a brief 
(10-15 minutes) telephone screening in order to provide them with information about the 
study and to assess their public speaking anxiety. To rule out generalized social anxiety, 
potential participants were assessed to determine whether they experienced clinically 
significant fears in social situations other than public speaking. Individuals who were 
deemed to be likely candidates for the study on the basis of the telephone screening were 
invited to the anxiety clinic to participate in a diagnostic interview. Trained 
diagnosticians (graduate and undergraduate psychology students) evaluated potential 
participants using the anxiety and mood portions of the SCID, as well as the ADIS. 
Diagnosticians were trained by the clinical supervisor (JDH), who provided an extensive 
overview of the assessment measures and assisted in practice administrations. After this 
initial training, diagnosticians then observed 1-2 assessments conducted by an advanced 
graduate student, and were subsequently observed by an advanced graduate student while 
administering an assessment. Reliability was assessed by comparing the diagnostic 
assessments of the diagnostician trainee and the advanced graduate student. All 
diagnostic evaluations were reviewed with one or both of the clinical supervisors for the 
study (JDH and EMF, both licensed clinical psychologists) prior to enrolling participants. 
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Individuals who did not meet criteria for the study, as assessed by the telephone 
screening and/or the diagnostic assessment, were referred to appropriate community 
resources. 
 Prior to the first treatment session, participants were assessed using all self-report, 
clinician-rated, and behavioral measures. Participants completed the self-report measures 
again at mid-treatment (i.e., between the third and fourth sessions). At post-treatment, all 
measures (self-report, clinician-rated, and behavioral) were again completed. At 6-week 
follow-up, the clinician-rated measures were completed over the phone with the 
participant, and participants again completed the self-report measures. Additionally, 
participants completed the BSQ at the beginning of each session and the RTQ at the 
conclusion of the first session. Table 1 illustrates the assessment schedule. All self-report 
measures (with the exceptions of the RTQ and the BSQ) were completed online using 
SurveyMonkey. 
  Table 1. Schedule of Assessments 
 
 Baseline Pre-Treatment After 1st 
session 
Mid-Treatment Post-Treatment Follow-up Weekly 
Self-report 
measures 
Demographics AAQ-II 
DDS 
PHLMS 
PRCA-24  
     (Public  
     Speaking  
     Subscale) 
   PRCS 
   QOLI 
   SSPS 
   STAI  
     (A-State) 
 
   RTQ AAQ-II 
DDS 
PHLMS 
PRCA-24  
     (Public  
     Speaking  
     Subscale) 
   PRCS 
   QOLI 
   SSPS 
   STAI (A-State) 
 
AAQ-II 
DDS 
PHLMS 
PRCA-24  
     (Public  
     Speaking  
     Subscale) 
   PRCS 
   QOLI 
   SSPS 
   STAI  
     (A-State) 
 
AAQ-II 
DDS 
PHLMS 
PRCA-
24  
     (Public  
     Speaking  
     Subscale) 
   PRCS 
   QOLI 
   SSPS 
   STAI  
     (A-State) 
 
    BSQ 
Clinician- 
rated 
measures 
 SCID 
 ADIS-IV 
 CGI-S 
      SCID 
   ADIS-IV 
   CGI-S 
   CGI-I 
   SCID 
   ADIS-IV 
   CGI-S 
   CGI-I 
 
Behavioral 
measures 
    BAT      BAT   
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Treatment groups of 4-8 participants were formed on a rolling admission basis.  
Groups of participants with a common available meeting time were assigned randomly to 
one of the two treatment conditions (ACT or HAB). In order to attain relatively equal 
sample sizes between the two conditions given the varying number of participants in each 
cohort, a total of four HAB cohorts and three ACT cohorts were treated. 
2.3.1. Treatments 
 Each of the two treatment conditions consisted of 6 two-hour group sessions. The 
first session consisted primarily of icebreaker activities and an explanation of the 
rationale (either acceptance/defusion or habituation) to be used in the sessions. 
Participants were assigned to complete an exposure hierarchy of feared public 
speaking/performance situations to bring to the second session. Beginning in the second 
session, participants engage in role-played exposure exercises consisting of various 
public speaking situations. These exposure exercises involved other group participants as 
well as confederates. At least 10 minutes of exposure exercises were allotted in each 
session (2-6) for each group member. In sessions 2-4, these exposure exercises were 
mainly impromptu speaking situations. In session 5, participants delivered a brief, 
prepared speech (assigned the week before) on a topic of their choice. The final session 
exposure consisted of singing karaoke-style in front of the group members and 
confederates. (Although this was not public speaking per se, it was included because it 
was considered a performance situation and was listed highly on many participants’ 
exposure hierarchies.) Each session concluded with a brief review and the assignment of 
homework, consisting of in vivo exposure tasks and exercises specific to the particular 
treatment modality. Therapists (doctoral students in clinical psychology) were trained by 
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the project coordinator and the Director of the Anxiety Treatment and Research Program 
(JDH) in administering each of the treatment protocols. A total of three therapists, 
including the project coordinator, provided treatment. Two therapists co-led each group; 
each therapist led at least two cohorts with each of the other therapists, in order to 
minimize experimenter effects. Junior therapists began by acting as a co-therapist with 
the project coordinator, gradually carrying more responsibility for sessions as treatment 
progressed. Weekly supervision meetings were conducted with the project coordinator.  
 2.3.1.1. Exposure with acceptance/defusion context (ACT). The treatment 
delivered in this condition utilized concepts derived from Acceptance and Commitment 
Therapy (Hayes, Strosahl, et al., 1999). Treatment first focused on the ineffectiveness of 
participants’ past attempts to control or reduce their anxiety in public speaking situations. 
As an alternative to these control attempts, the notion of acceptance of one’s private 
experiences (thoughts, feelings, sensations) was introduced as a key concept. Treatment 
focused on “willingness” to experience unwanted thoughts and feelings while 
simultaneously engaging in valued activities, especially those related to public speaking. 
A second key concept, cognitive defusion, focused on teaching participants to view 
themselves as separate from their internal experiences, thereby allowing the private 
experiences to occur without preventing the participant’s engagement in exposure 
exercises. Techniques designed to foster acceptance and defusion were presented and 
practiced prior to and during exposure exercises, and were assigned as homework 
between sessions.  
The techniques used in the sessions (described further in Hayes, Strosahl, et al., 
1999) were adapted as needed to suit a group therapy setting, and were also modified for 
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use as homework assignments. One example of a defusion exercise used in session is 
“Picking Up The Pen.” In this exercise, each group member held a pen in the palm of his 
or her hand, and repeated the words “I can’t pick up the pen” several times while lifting 
the pen with the opposite hand, thus demonstrating that thoughts are not always true. The 
practice of mindfulness meditation is similarly versatile. In session, therapists guided all 
group members simultaneously through the process of mindfulness meditation (using 
guided imagery, such as imagining one’s thoughts placed upon leaves flowing on a 
stream). As a homework assignment, participants were assigned to practice mindfulness 
meditation individually, recalling the exercise demonstrated by the therapist. See 
Appendix A for the ACT treatment manual developed and used for this study. 
 2.3.1.2. Exposure with habituation context (HAB). The context for exposure in 
this condition involved explanations of behavioral principles, including classical and 
operant conditioning and habituation. The rationale for exposure utilized material from 
Salkovskis and colleagues’ (2007) habituation-based exposure therapy (HBET) 
condition. Participants were told that, according to principles of classical conditioning, 
they had learned to associate public speaking situations with unwanted feelings of 
anxiety. It was explained that, when they avoid or escape public speaking situations, the 
resulting decrease in anxiety raises the likelihood that they will do so in the future. 
Participants were then taught the underlying principle of habituation; that is, that anxiety 
tends to decrease as a result of repeated and prolonged exposure to feared situations. 
When engaging in exposure exercises (both in session and assigned homework 
exercises), participants were encouraged to remain in the feared speaking situation until 
their anxiety (i.e., SUDS rating) decreased.  
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 During sessions, group members were prompted for SUDS ratings at various 
points during their individualized exposure exercises; these prompts were gradually faded 
across sessions. These SUDS ratings were charted on a white board in front of the group, 
in order to demonstrate the pattern of anxious arousal experienced throughout the 
exposure exercise. Participants were asked to record their anxiety levels in a similar 
manner (including at least 3 data points) during exposure exercises completed for 
homework. See Appendix A for the HAB treatment manual developed and used for this 
study. 
2.4. Ethical Issues 
 Informed consent was obtained from all participants. They were informed that 
they could refuse to participate or stop at any time. Participants were told that they might 
experience anxiety during treatment sessions, particularly while completing the exposure 
exercises. Such anxiety is to be expected given the nature of public speaking fears, and 
was addressed in treatment sessions. No adverse reactions occurred during the study. 
 Data has been stored separately from the informed consent forms, and no 
identifying information has been stored with the data. Each participant’s data has been 
identified by a subject number. Only the project coordinator has access to participants’ 
personal information. All data and informed consent forms will be stored for at least three 
years following completion of the study, in accordance with Drexel University’s IRB 
guidelines. 
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CHAPTER 3: RESULTS 
3.1. Preliminary Analyses 
 The two treatment conditions were compared on demographic, outcome, and 
process variables using t-tests; no pre-existing differences were found between the two 
conditions. Data were inspected and tested to ensure that they met the assumptions of an 
analysis of variance (ANOVA) model (e.g., normal distribution, homogeneity of variance 
and covariance). Data were plotted for visual examination and inspected for outliers and 
normal distribution, and tested for skewness and kurtosis. Data were tested using 
Levene’s test for homogeneity of variance. No extreme problems with distribution were 
found; therefore, it was not necessary to transform the data to meet the assumptions of the 
ANOVA model. No between-groups differences were found on a measure of treatment 
outcome expectancy (RTQ; t (43) = -1.16, p = .25). 
3.2. Main Analyses  
Unless otherwise specified, all data were analyzed using an intent-to-treat model. 
For any participants with missing data points (i.e., dropout), the last completed data point 
was carried forward. To address the issue of low power, analyses focused on effect sizes 
in addition to significance values. No pre-existing differences were found between 
completers and non-completers on either demographic variables or on baseline measures 
of public speaking anxiety, state anxiety, quality of life, or any of the treatment process 
measures. Descriptive statistics for outcome and process measures at each assessment 
point, separated by treatment condition, are displayed in Tables 2-9. 
Hypothesis 1.  The effects of treatment on the various outcome measures were 
assessed via a series of 2 (treatment condition) X 4 (assessment occasion) mixed 
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repeated-measures ANOVAs, using assessment point (pre-treatment, mid-treatment, post-
treatment, and follow-up) as the within-participants variable and treatment condition 
(ACT or HAB) as the between-participants variable. It was hypothesized that a time-by-
condition interaction would occur, with greater improvement on outcome measures for 
the ACT group. This hypothesis was not supported; there were no significant between-
groups differences or interactions between the two conditions on any of the outcome 
measures. However, there were significant within-groups differences on most of the 
measures over time. Results for each of the outcome measures are displayed in Table 10 
and described briefly below. 
Completer analyses revealed no significant differences between conditions on 
caseness, defined by diagnostic rating on the SCID (F (1, 32) = .52, p = .48, η2p = .02), or 
on clinician severity ratings (F (1, 32) = .46, p = .50, η2p = .01). A similar pattern of 
results was obtained for intent-to-treat analyses (see Table 10). For completers, there was 
a significant main effect of time on SCID diagnostic rating (F (2, 66) = 129.86, p < .001, 
η2p = .80). This result remained significant when the data were analyzed using an intent-
to-treat model (F (2, 86) = 76.45, p < .001, η2p = .64). At post-treatment, all but two 
participants who completed treatment (both in the HAB condition) no longer met criteria 
for SAD. At 6-week follow-up, all but one completer had improved to either partial or 
full remission. 
Significant improvement was observed on self-report measures of public speaking 
(PRCA, PRCS, SSPS) for both conditions from pre- to post-treatment; these gains were 
maintained at 6-week follow-up (see Figures 1-4). Within-subjects effect sizes (η2p) for 
these measures ranged from .43 to .56 (F = 27.85 to 53.32, all p < .001).  Between-groups 
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effect sizes and time-by-condition interactions were generally small and non-significant 
(see Table 10). There were no differences in BAT speech duration across conditions or 
assessment points; however, there was a significant reduction in highest self-reported 
anxiety (SUDS) across conditions from pre- to post-treatment (F (1, 43) = 35.36, p < 
.001, η2p = .45; see Figure 5). A similar reduction from pre- to post-treatment was found 
for both pre-BAT SUDS and post-BAT SUDS. No between-groups differences in SUDS 
were observed, with the exception of a small main effect of treatment condition on 
baseline SUDS (F (1, 43) = 6.97, p = .01, η2p = .14). Observer-rated social skills for the 
BAT improved significantly from pre- to post-treatment (for overall social skills, F (1, 
43) = 13.06, p < .001, η2p = .23; similar patterns obtained for individual types of social 
skills) and did not differ between treatment conditions. No significant within- or 
between-groups differences were observed on self-report measures of overall state 
anxiety (STAI) or quality of life (QOLI); between-groups effect sizes were small (η2p = 
.01 and .03, respectively). 
A significant main effect (increase) was observed for self-reported defusion 
(DDS; F (3, 99) = 12.03, p < .001, η2p = .27; see Figure 6). The between-groups and 
interaction effects were not significant (see Table 11). No significant within- or between-
groups effects were obtained for mindfulness (PHLMS) or for psychological acceptance 
(AAQ-II), although the within-groups effect for the PHLMS-Acceptance approached 
significance (F (3, 96) = 2.54, p = .06, η2p = .07). These data are displayed in Table 11. 
Hypothesis 2. Due to the lack of significant between-groups differences on 
outcome measures, it was not possible to conduct formal mediational analyses in order to 
test the hypothesis that acceptance, defusion, or mindfulness would mediate treatment 
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outcome. Therefore, a partial mediational analysis was conducted by correlating 
residualized change scores for the predictor variables and outcome variables across 
overlapping and non-overlapping time points. Changes in the predictor variables 
(acceptance, defusion, and mindfulness) from pre- to mid- and from pre- to post-
treatment were correlated with changes in the outcome variables from mid- to post-
treatment and from mid-treatment to follow-up. These relationships were examined both 
for the overall sample and for each treatment condition separately. A variety of 
significant correlations were found, although there did not appear to be a clear pattern 
across specific time frames and measures. In general, the relationships between the 
process and outcome measures were as expected; that is, increases in defusion, 
mindfulness, and acceptance generally predicted improvement in the outcome measures. 
No clear-cut differences were observed between the two treatment conditions with 
respect to mediation. Significant correlations are displayed in Tables 12-15. 
Hypothesis 3. To examine the hypothesized relationships between baseline levels 
of public speaking anxiety, overall anxiety, quality of life, acceptance, mindfulness, 
defusion, and social skills, a correlational analysis was used to assess relationships 
between the behavioral, self-report, and clinician-rated measures at baseline. Higher 
baseline state anxiety on the STAI was associated with lower baseline scores on the 
QOLI, PHLMS-Acceptance, and AAQ-II. Greater baseline scores on the SSPS-Negative 
were associated with lower baseline scores on the PHLMS-Acceptance, AAQ-II, and 
DDS. These correlations are displayed in Table 16. 
Hypothesis 4. To examine the moderating effects of baseline levels of acceptance, 
defusion, and mindfulness on overall treatment response, a correlational analysis was 
  
51 
used to assess the relationship between baseline measures of these variables and 
residualized gain scores on public speaking anxiety, overall anxiety, quality of life, and 
social skills.  In the ACT condition only, baseline defusion as measured by the DDS was 
significantly and negatively correlated with change in overall state anxiety on the STAI 
A-State from pre- to post-treatment (r = -.52, p = .03) and from pre-treatment to follow-
up (r = -.61, p = .001). For the overall sample, baseline acceptance on the AAQ-II was 
significantly and negatively correlated with mid-to-post-treatment change on the STAI (r 
= -.39, p = .01); however, this relationship was not significant within either of the two 
treatment conditions when they were examined separately. For the ACT condition, 
baseline AAQ-II scores were positively correlated with changes in quality of life (QOLI) 
from mid- to post-treatment (r = .44, p < .05). The opposite was true for the Habituation 
condition: baseline AAQ-II scores were negatively correlated with change on the QOLI 
from pre-treatment to follow-up (r = -.43, p = .04). For the overall sample, baseline 
mindful acceptance (PHLMS-Acceptance) was significantly and negatively correlated 
with mid-to-post-treatment change in the STAI A-State (r = -.32, p = .04). Within the 
ACT condition, baseline PHLMS-Acceptance scores were positively correlated with mid-
to-post-treatment change in public speaking confidence on the PRCS (r = .45, p < .05). 
For the Habituation condition, baseline PHLMS-Acceptance scores were negatively 
correlated with mid-to-post-treatment changes on the SSPS-Positive (r = -.43, p < .05). 
For the overall sample, baseline mindful awareness (PHLMS-Awareness) was 
significantly and negatively correlated with mid-to-post-treatment change in negative 
cognitions related to public speaking on the SSPS-Negative (r = -.30, p < .05). Baseline 
awareness was significantly and positively correlated with changes on the SSPS-Positive 
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across the following time points: pre-to-post (r = .43, p < .01), mid-to-post (r = .32, p = 
.03), pre-to-follow-up (r = .52, p < .001), and mid-to-follow-up (r = .43, p < .01). Similar 
relationships between baseline PHLMS-Acceptance and the SSPS were found within the 
two treatment conditions. These correlations are displayed in Table 17. 
 Hypothesis 5. Total duration of exposure (in minutes) completed for homework 
was calculated for participants in both treatment conditions. Homework data were 
available for only 37 participants (19 HAB, 18 ACT). These values were compared using 
an independent-samples t-test to examine between-condition differences. Mean total 
exposure homework completed was 98.18 minutes for the HAB condition and 97.69 
minutes for the ACT condition; this difference was not significant (t (35) = .01, p = .99).  
Hypothesis 6. Due to the lack of significant between-groups differences on 
amount of exposure homework completed, it was not possible to conduct a formal 
mediational analysis in order to test the hypothesis that duration of exposure would 
mediate treatment outcome. A 2 (treatment condition) X 4 (session number) mixed 
repeated-measures ANOVA was used to examine within- and between-conditions 
differences in reported homework exposure duration across the four sessions (3-6) for 
which homework exposure duration was collected. No significant differences were found 
between conditions (F (1, 35) < .001, p = .99, η2p < .001) or across sessions (F (3, 105) = 
.53, p = .67, η2p = .02). The time-by-condition interaction was also not significant (F (3, 
105) = 2.26, p = .09, η2p = .06). Therefore, no mediational analyses were conducted for 
exposure homework. 
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CHAPTER 4: DISCUSSION 
 The present study examined the relative efficacy of exposure delivered within two 
contexts (acceptance versus habituation) for the treatment of public speaking anxiety 
(non-generalized social anxiety disorder) in a clinical population. Treatment was 
delivered in a group format over 6 weekly 2-hour sessions. Analyses of baseline 
measures revealed no pre-existing differences between the two treatment conditions on 
demographic, outcome, or process variables; moreover, treatment expectancies were 
equal for participants in both treatments. Of the 45 participants who enrolled (i.e., 
attended at least one treatment session), 35 were classified as completers (19 in the 
habituation condition, and 16 in the acceptance condition). Data were analyzed using an 
intent-to-treat model. Contrary to hypotheses, no significant differences were found 
between the two treatment conditions on outcome or process measures. Between-groups 
effect sizes were generally small, suggesting that the lack of significant findings was not 
due to low statistical power. All participants who completed treatment had improved 
significantly at post-treatment; these gains were maintained at follow-up. Of the 
treatment completers, all but one no longer met criteria for social anxiety disorder at 6-
week follow-up. For participants in both treatment conditions, there was significant 
improvement on self-reported public speaking anxiety, confidence in public speaking, 
and self-statements related to public speaking, as well as self-reported anxiety and 
observer-rated social skills on a behavioral speech task. There was also a significant 
increase for both conditions on self-reported defusion. These results suggest that 
exposure with either an acceptance- or habituation-based rationale and context is an 
effective treatment for public speaking anxiety. No significant changes were observed for 
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self-reported overall state anxiety, quality of life, acceptance, or mindfulness, or for 
behavioral avoidance (speech task duration).  
 In addition to comparing treatment efficacy, a secondary aim of this study was to 
examine differences in mechanisms of action (mediators) across the two treatment 
conditions. For both conditions, increases in defusion from pre-to-mid treatment were 
associated with increases in positive and decreases in negative public-speaking-related 
cognitions from mid-to-post-treatment. Interestingly, increases in mindful awareness 
predicted decreases in public speaking anxiety for the habituation group, whereas the 
opposite was true for the acceptance-based group. This may be due to the difference in 
the way that anxiety was characterized in the two treatment conditions. In the habituation 
condition, participants were primed to become aware of decreasing SUDS levels, as they 
were told that habituation would occur during and across exposure practices. Therefore, it 
makes theoretical sense that as their awareness increased they became more attuned to 
the habituation process. Conversely, participants receiving the acceptance-based 
intervention were taught that anxiety would not necessarily decrease; therefore, these 
individuals were more likely to notice increased, rather than decreased, anxiety as their 
awareness was heightened. In contrast, for participants in this condition, increases in 
mindful acceptance were associated with decreased public speaking anxiety; this is 
consistent with previous research that has found reduction in symptoms as a result of 
acceptance-based treatment, despite this not being the focus of the therapy.  Finally, for 
participants in the acceptance-based condition, pre-to-mid-treatment increases in mindful 
acceptance predicted a temporary (mid-to-post-treatment) decrease in self-reported 
quality of life; however, this association was no longer present when pre-to-mid-
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treatment change in mindfulness was examined in relation to mid-to-follow-up change in 
outcome.  
 Despite the minor variations within these findings, no clear patterns of results 
were observed across the two treatment conditions. Therefore, the results do not appear to 
provide evidence of differential mediational processes for ACT-based versus habituation-
based exposure. 
As expected, across conditions, lower overall state anxiety was associated with 
greater self-reported quality of life, mindfulness, and acceptance, at baseline. Participants 
with lower baseline levels of negative public-speaking-related cognitions also had greater 
self-reported mindfulness and acceptance, as well as higher scores on a self-report 
measure of cognitive defusion. These findings are consistent with ACT’s assertion that 
mindfulness, acceptance, and defusion are associated with greater psychological health 
and less pathology. As hypothesized, for the overall sample, baseline acceptance and 
mindfulness moderated treatment response with respect to overall state anxiety and 
public-speaking-related cognitions. Specifically, greater baseline acceptance (as 
measured by both the AAQ-II and the PHLMS-Acceptance) predicted mid-to-post-
treatment decrease in overall state anxiety, whereas greater mindful awareness at baseline 
was associated with decreased negative and increased positive self-statements related to 
public speaking. These patterns were generally consistent across both treatment 
conditions (although the relationship between acceptance and state anxiety was not 
significant within either of the two treatment conditions when examined separately). 
These results suggest that the ability to be mindful and to accept one’s internal 
experiences nonjudgmentally can enhance one’s capacity to benefit from exposure 
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treatment, at least with respect to self-reported anxiety and public-speaking-related 
cognitions. Again, this is consistent with the notion that these capabilities are associated 
with psychological flexibility. Interestingly, greater baseline defusion predicted decreases 
in state anxiety for the ACT condition only. As only the ACT participants were explicitly 
taught defusion strategies, it is possible that participants in this group who had high 
baseline defusion skills were better able to utilize specific defusion strategies once they 
were taught, thus decreasing overall anxiety. Another between-groups difference was the 
relationship between baseline acceptance on the AAQ-II and changes in quality of life. 
For the ACT group, this relationship was in the expected direction: greater baseline 
acceptance predicted improvement in quality of life. However, higher baseline 
acceptance predicted a decrease in quality of life for the habituation condition. Although 
it is possible that this result was an artifact, another potential interpretation may be that 
ACT participants were explicitly told that acceptance would help them, whereas the 
habituation group was told that their symptoms would change (i.e., they were essentially 
instructed NOT to accept their unwanted experiences). Therefore, individuals in the 
habituation group who were already using acceptance strategies may have found it more 
difficult to utilize non-acceptance-based techniques, which could theoretically have had a 
negative impact on psychological health. As with the partial mediational analyses above, 
it is difficult to draw definitive conclusions regarding differential moderation processes 
between the two treatment conditions based upon these results. 
No differences were observed between the two treatment conditions for total 
amount of homework exposure completed; there were also no within-participants 
differences across sessions. It is possible that the lack of significant findings is due to the 
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large rate of non-compliance with homework (at least, in terms of recording exposure 
duration). Only 37 of the 45 enrolled participants turned in any recorded homework, and 
many of these did not turn in homework every week. It is unclear to what extent the lack 
of homework compliance was a reflection of behavioral avoidance due to anxiety, versus 
lack of motivation to record exposure practice. Additionally, there was significant 
variation in the way that participants reported exposure duration. For example, some 
participants would report a 3-hour class in which they participated in class discussion as 3 
hours of exposure; others would report only the number of minutes they actually spoke 
during the class. Although efforts were made, whenever possible, to determine the actual 
number of minutes spent in public speaking situations, the reported homework duration 
in this study is likely not a fully accurate reflection of participants’ exposure practice. 
Future studies should attempt to enforce a more uniform procedure for reporting 
homework exposure duration. 
Theoretically, the context in which exposure treatment is delivered could lead to 
differential effects in two ways: 1) by altering expectations for treatment, or 2) by 
changing behavior (i.e., by altering participants’ willingness to engage in exposure, 
thereby leading them to engage in more or less exposure). There are several possible 
explanations for the current study’s lack of between-groups differences in treatment 
outcome. One possibility, despite the small effect sizes, is that the analyses failed to 
detect differences due to insufficient power. A more likely explanation is that exposure-
based treatment, regardless of the context in which it is delivered, is so powerful that it 
tends to produce change large enough to obscure any between-groups differences. 
Controlling for non-specific treatment factors is essential when comparing treatment 
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rationales. Perhaps adding more components to the interventions in order to increase the 
differences between them (e.g., values/motivational enhancement for the ACT group) 
might have resulted in greater variation. It is also possible that the in-session exposures 
were not difficult enough to result in differential levels of participation across conditions. 
A more heterogeneous sample, with a greater range of anxiety severity, might have 
produced more dramatic between-groups effects. For example, it is possible that 
individuals with more severe public speaking anxiety may respond differently to 
exposure treatment depending on the rationale presented. In the same vein, a non-clinical, 
non-treatment-seeking population may yield differential results depending on treatment 
context, as was found by Block and Wulfert (2000). Measuring additional variables, such 
as specific social-skills-related behaviors, physiological indicators of anxiety, and 
defensive safety behaviors, might also have provided evidence for differential effects.  
Finally, mechanisms of action for the two treatment contexts may be more alike 
than different. Anecdotally, several participants in the habituation condition 
spontaneously reported using defusion and acceptance strategies. For example, one 
participant in the habituation condition stated that he could “watch” his SUDS level 
decrease during public speaking exposure, but that he viewed this as separate from his 
behavior in the moment (“I can see my SUDS change over there, but I’m speaking over 
here”). The idea that individuals may use acceptance and defusion strategies during 
exposure, even when not explicitly taught to do so, is worthy of further investigation.  
4.1. Strengths and limitations. A notable strength of the present study is its 
experimental design; participants were randomly assigned to treatment condition, thus 
allowing conclusions to be drawn regarding treatment effects. Additionally, this study 
  
59 
utilized a clinical population, assessed via clinical interview; therefore, results can more 
readily be generalized to a treatment-seeking population meeting criteria for non-
generalized social anxiety disorder. A significant limitation of this study is the small 
sample size, resulting in lower power for the statistical analyses. Although this limitation 
was taken into account via the examination of effect sizes, it remains possible that 
significant effects may have been missed due to insufficient power. Another limitation 
was the method for recording homework exposure duration. Compliance with homework 
exposure, at least with respect to recording duration, was less than optimal. In the future, 
a stricter enforcement procedure for homework recording may produce more valid 
results. 
4.2. Conclusions and future directions. Overall, the present pilot study 
demonstrated that an acceptance-based exposure intervention can be implemented 
feasibly in a group setting for the treatment of public speaking anxiety, and that such an 
intervention may be at least as effective as a more traditional habituation-based exposure 
treatment. Overall, the exposure treatment was quite effective in reducing public 
speaking anxiety, as measured by pre-to-post-treatment/follow-up effect sizes. This 
improvement occurred absent any direct cognitive change strategies, such as those 
typically used in cognitive therapy. Although no specific conclusions can be drawn on 
this point due to the absence of an exposure-with-cognitive-change condition, these 
results nevertheless add to the growing evidence that direct cognitive change 
interventions may often be superfluous (Longmore & Worrel, 2007). 
Despite the lack of between-groups differences, it is possible that some 
participants may respond more readily to an acceptance-based rationale for exposure, as 
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opposed to a habituation rationale. Baseline anxiety severity, treatment history (e.g., 
treatment-resistant versus non-treatment-resistant), and various demographic variables 
could all be potential moderators of the relationship between exposure rationale and 
treatment outcome.  
The question also remains as to whether or not a rationale for exposure is truly 
necessary. Although it may be difficult to convince individuals to engage in exposure 
without an explanation, there may be particular populations who respond best simply to 
being told what to do (for example, military veterans who are accustomed to taking 
orders). Further research is needed to elucidate the most effective context for public 
speaking exposure treatment for a given individual. Larger sample sizes and more 
effective methods of recording between-session exposures are indicated. More broadly, 
future research should focus on examining mechanisms of action for exposure treatment, 
not only for public speaking anxiety, but for other disorders in which exposure is a major 
therapeutic ingredient. 
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Table 2. Descriptive Statistics for Outcome Measures at Pre-Treatment 
 
 
 
 
 
 
 
 ACT Habituation 
     Measure N Mean SD N Mean SD 
Clinician-Rated       
     CGI 21 4.29 .46 24 4.29 .46 
Self-Report       
     PRCA 21 27.57 2.79 24 26.21 2.43 
     PRCS 21 2.33 1.65 24 2.58 1.38 
     SSPS-Positive 21 14.71 4.10 23 15.22 4.44 
     SSPS-Negative 21 17.81 5.02 23 18.48 5.33 
     STAI  19 33.47 10.01 24 32.79 10.20 
     QOLI (Mean 
Score) 
21 2.06 1.53 24 1.86 1.19 
Behavioral       
     Duration (sec) 21 152.19  152.55 24 147.50 129.85 
     Baseline SUDS 21 33.33 14.94 24 26.00 12.13 
     Pre-SUDS 21 30.95 13.75 24 31.58 12.33 
     Post-SUDS 21 50.24 22.67 24 57.08 19.16 
     Highest SUDS 21 64.67 16.01 24 68.58 15.25 
     Verbal SS 21 2.67 .91 24 2.50 1.18 
     Nonverbal SS 21 2.10 .70 24 2.00 1.18 
     Paralinguistic SS 21 2.24 .83 24 2.21 1.02 
     Overall SS 21 2.24 .83 24 2.25 1.15 
     Observed SUDS 21 60.81 18.35 24 65.62 22.69 
  
78 
 
Table 3. Descriptive Statistics for Outcome Measures at Mid-Treatment (Self-report only)   
— Intent-to-Treat 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ACT Habituation 
Measure N Mean SD N Mean SD 
     PRCA 21 24.57 3.70 24 24.13 3.68 
     PRCS 21 3.24 2.26 24 4.25 2.72 
     SSPS-Positive 21 17.14 3.80 24 16.58 4.19 
     SSPS-Negative 21 16.29 4.98 24 16.25 5.26 
     STAI  20 35.20 10.78 24 35.00 12.01 
     QOLI (Mean)  21 2.22 1.13 24 2.06 1.22 
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Table 4. Descriptive Statistics for Outcome Measures at Post-Treatment (Intent-to-Treat) 
 
 
 
 
 
 
 ACT Habituation 
     Measure N Mean SD N Mean SD 
Clinician-Rated       
     CGI  21 2.52 1.12 24 2.54 1.10 
Self-Report       
     PRCA 21 21.00 3.55 24 22.21 3.51 
     PRCS 21 5.48 3.46 23 6.43 3.54 
     SSPS-Positive 21 19.81 4.60 24 19.75 4.22 
     SSPS-Negative 21 13.19 4.81 24 13.58 5.35 
     STAI  20 32.85 9.38 24 35.13 13.02 
     QOLI (Mean) 
Score) 
21 2.19 1.27 24 2.18 1.08 
Behavioral       
     BAT duration   
     (sec) 21 135.33  117.56 24 196.63 158.43 
     Baseline SUDS 21 28.57 11.85 24 21.71 8.61 
     Pre-SUDS 21 28.33 12.08 24 23.21 8.59 
     Post-SUDS 21 35.10 23.09 24 30.75 19.43 
     Highest SUDS 21 48.24 20.81 24 45.33 19.01 
     Verbal SS 21 3.14 .85 24 3.33 1.20 
     Nonverbal SS 21 2.62 .74 24 2.79 1.06 
     Paralinguistic SS 21 2.71 .78 24 2.75 .90 
     Overall SS 21 2.81 .75 24 2.88 1.04 
     Observed SUDS 21 50.00 17.31 24 49.71 18.47 
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Table 5. Descriptive Statistics for Outcome Measures at 6-Week Follow-Up (Intent-to- 
              Treat) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ACT Habituation 
Measure N Mean SD N Mean SD 
Clinician-Rated       
     CGI  21 2.19 1.25 24 2.37 1.25 
Self-Report       
     PRCA 21 21.05 3.79 24 21.17 4.10 
     PRCS 21 6.10 3.43 24 6.25 3.60 
     SSPS-Positive 21 20.67 4.81 24 18.67 4.28 
     SSPS-Negative 21 12.43 4.34 24 13.75 5.10 
     STAI  20 32.30 8.90 24 37.29 12.50 
     QOLI (Mean) 21 2.37 1.32 24 2.00 1.07 
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Table 6. Descriptive Statistics for Process Measures at Pre-Treatment  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ACT Habituation 
     Measure N Mean SD N Mean SD 
     AAQ-II 21 51.95 10.54 23 49.35 9.24 
     DDS 20 32.85 7.10 24 33.00 7.55 
     PHLMS-  
     Awareness 20 34.70 6.67 24 33.29 5.54 
     PHLMS-   
     Acceptance  20 33.75 5.61 22 31.64 6.43 
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Table 7. Descriptive Statistics for Process Measures at Mid-Treatment (Intent-to-Treat) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ACT Habituation 
     Measure N Mean SD N Mean SD 
     AAQ-II 21 50.67 8.77 23 52.04 8.80 
     DDS 17 34.47 8.29 21 35.05 6.67 
     PHLMS-  
     Awareness 21 35.67 5.56 23 34.17 4.86 
     PHLMS- 
     Acceptance  20 31.40 6.02 22 31.45 5.80 
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Table 8. Descriptive Statistics for Process Measures at Post-Treatment (Intent-to-Treat) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ACT Habituation 
     Measure N Mean SD N Mean SD 
     AAQ-II 20 53.40 7.81 24 50.54 10.60 
     DDS 16 39.06 7.40 24 36.38 6.70 
     PHLMS- 
     Awareness 20 35.60 5.25 23 34.83 5.28 
     PHLMS- 
     Acceptance  19 32.84 5.71 24 32.79 7.16 
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Table 9. Descriptive Statistics for Process Measures at 6-Week Follow-Up (Intent-to- 
              Treat) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ACT Habituation 
     Measure N Mean SD N Mean SD 
     AAQ-II 20 54.10 8.93 23 51.96 9.92 
     DDS 18 40.56 8.11 23 36.91 6.44 
     PHLMS- 
     Awareness 19 36.32 5.04 22 34.77 5.44 
     PHLMS- 
     Acceptance  20 33.95 5.60 20 32.70 7.16 
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Table 10. Effects of Time and Treatment Condition on Outcome (Intent-to-Treat) 
 Within-Ss Effects  (Time) 
Between-Ss Effects 
(Condition) 
Interaction 
(Time x Condition) 
     Measure F df p η2p F df p η2p F df p η2p 
Clinician-
Rated             
     SCID 76.45 (2, 86) .001 .64 .69 (1, 43) .41 .02 .33 (2, 86) .72 .01 
     CGI-S 101.59 (2, 86) .001 .70 .08 (1, 43) .78 .002 .21 (2, 86) .81 .01 
Self-Report             
     PRCA 53.32 (3, 126) .001 .56 .09 (1, 42) .76 .002 1.97 (3, 126) .12 .05 
     PRCS 29.90 (3, 120) .001 .43 1.24 (1, 40) .27 .03 .66 (3, 126) .58 .02 
     SSPS-Pos 33.41 (3, 108) .001 .48 2.06 (1, 36) .16 .05 1.70 (3, 108) .17 .05 
     SSPS-Neg 27.85 (3, 111) .001 .43 .24 (1, 37) .63 .01 .70 (3, 111) .55 .02 
     STAI  1.08 (3, 105) .36 .03 .21 (1, 35) .65 .01 .65 (3, 105) .58 .02 
     QOLI  1.57 (3, 120) .20 .04 1.23 (1, 40) .27 .03 .80 (3, 120) .49 .02 
Behavioral   
     Duration  
     (sec) .91 (1, 43) .35 .02 .54 (1, 43) .47 .01 3.81 (1, 43) .06 .08 
     Baseline  
     SUDS 3.65 (1, 43) .06 .08 6.97 (1, 43) .01 .14 .01 (1, 43) .92 .001 
     Pre-SUDS 6.65 (1, 43) .01 .13 .65 (1, 43) .43 .02 1.82 (1, 43) .18 .04 
     Post-  
     SUDS 38.04 (1, 43) .001 .47 .06 (1, 43) .82 .001 2.77 (1, 43) .10 .06 
     Highest  
     SUDS 35.36 (1, 43) .001 .45 .02 (1, 43) .90 .001 1.05 (1, 43) .31 .02 
     Verbal SS 15.13 (1, 43) .001 .26 .002 (1, 43) .97 .001 1.13 (1, 43) .30 .03 
     Nonverbal  
     SS 16.28 (1, 43) .001 .28 .03 (1, 43) .87 .001 .68 (1, 43) .42 .02 
     Paraling. 
     SS 11.04 (1, 43) .002 .20 .001 (1, 43) .99 .001 .05 (1, 43) .83 .001 
     Overall SS 13.06 (1, 43) .001 .23 .03 (1, 43) .87 .001 .03 (1, 43) .87 .001 
     Observed  
     SUDS 15.59 (1, 43) .001 .27 .23 (1, 43) .63 .01 .57 (1, 43) .46 .01 
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Table 11. Effects of Time and Treatment Condition on Process Measures (Intent-to-Treat) 
 
 
 Within-Ss Effects (Time) Between-Ss Effects (Condition) Interaction (Time x Condition) 
     Measure F df p η2p F df p η2p F df p η2p 
     AAQ-II 1.42 (3, 117) .24 .04 1.18 (1, 39) .28 .03 1.85 (3, 117) .14 .05 
     DDS 12.03 (3, 99) .001 .27 2.40 (1, 33) .13 .07 1.38 (3, 99) .25 .04 
     PHLMS- 
     Awareness 1.99 (3, 111) .12 .05 .40 (1, 37) .53 .01 .01 (3, 111) .99 .001 
     PHLMS- 
     Acceptance 2.54 (3, 96) .06 .07 .03 (1, 32) .86 .001 1.23 (3, 96) .30 .04 
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Table 12. Correlations Between Residualized Pre-to-Mid-Treatment Change in Predictor  
Variables and Residualized Mid-to-Post-Treatment Change in Outcome    
Variables —Intent-to-Treat (Significant Correlations Only) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Process Variable  
(Pre-to-Mid Change) 
Outcome Variable  
(Mid-to-Post Change) r p 
 Overall Sample    
     DDS              SSPS-Negative -.45 .01 
     PHLMS-Acceptance              PRCA -.31 .04 
 ACT    
     DDS              SSPS-Negative -.48 .03 
              SSPS-Positive .42 .04 
     PHLMS-Acceptance              QOLI -.45 .05 
              PRCA -.52 .02 
     PHLMS-Awareness              PRCA .47 .04 
Habituation    
     DDS              SSPS-Negative -.49 .02 
                   SSPS-Positive .42 .04 
     PHLMS-Awareness              PRCA -.49 .02 
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Table 13. Correlations Between Residualized Pre-to-Mid-Treatment Change in Predictor  
Variables and Residualized Mid-to-Follow-Up Change in Outcome Variables   
— Intent-to-Treat (Significant Correlations Only)
Process Variable  
(Pre-to-Mid Change) 
Outcome Variable  
(Mid-to-Follow-Up Change) r p 
 Overall Sample    
     DDS             SSPS-Negative -.40 .01 
     PHLMS-Acceptance            PRCA -.31 .05 
     AAQ-II            PRCS .34 .03 
 ACT    
     PHLMS-Acceptance            PRCA -.47 .04 
Habituation    
     DDS            SSPS-Negative -.59 .01 
                 SSPS-Positive .59 .01 
     AAQ            PRCS .44 .04 
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Table 14. Correlations Between Residualized Pre-to-Post-Treatment Change in Predictor  
Variables and Residualized Mid-to-Follow-Up Change in Outcome Variables  
     — Intent-to-Treat (Significant Correlations Only)
 
 
Process Variable  
(Pre-to-Post Change) 
Outcome Variable  
(Mid-to-Follow-Up Change) r p 
 Overall Sample    
     DDS           SSPS-Negative -.48 .001 
           SSPS-Positive .44 .01 
           STAI -.30 .05 
           PRCA -.44 .01 
           PRCS .47 .001 
     PHLMS-Acceptance           PRCA -.57 .001 
           PRCS .37 .02 
     PHLMS-Awareness           SSPS-Negative -.31 .04 
     AAQ-II           SSPS-Negative -.37 .01 
           STAI -.36 .02 
 ACT    
     DDS           PRCS .46 .04 
     PHLMS-Acceptance           PRCA -.68 .001 
Habituation    
     DDS           SSPS-Negative -.56 .01 
                SSPS-Positive .71 .001 
                PRCA -.62 .001 
           PRCS .49 .01 
     PHLMS-Acceptance           PRCA -.52 .01 
     PHLMS-Awareness           PRCS .46 .03 
     AAQ-II           STAI -.55 .01 
             PRCS .42 .05 
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Table 15. Correlations Between Residualized Pre-to-Post-Treatment Change in Predictor  
Variables and Residualized Post-to-Follow-Up Change in Outcome Variables   
— Intent-to-Treat (Significant Correlations Only) 
 
 
 
 
 
 
 
 
 
 
Process Variable  
(Pre-to-Post Change) 
Outcome Variable  
(Post-to-Follow-Up Change) r p 
 Overall Sample    
     DDS             SSPS-Positive .30 .05 
     PHLMS-Acceptance             PRCA -.39 .01 
     PHLMS-Awareness             QOLI -.32 .04 
                  SSPS-Negative -.31 .04 
             STAI .31 .04 
 ACT    
     PHLMS-Acceptance             QOLI .45 .05 
Habituation    
     DDS             SSPS- Positive .61 .001 
                  PRCA -.52 .01 
     PHLMS-Awareness             SSPS-Negative -.59 .01 
             STAI .53 .01 
             PRCS .50 .02 
     AAQ-II             SSPS-Positive .59 .01 
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Table 16. Correlation Matrix of Baseline Measures 
*** p ≤ 0.001, ** p < 0.01, * p < 0.05 
 
 
 
 
 
 
 
 
 
 
     Measure PRCS SSPS-P SSPS-N STAI QOLI 
PHLMS-
Accept 
PHLMS-
Aware AAQ-II DDS 
Overall 
SS 
     PRCA -.71*** -.43** .31* -.06 -.03 .12 -.15 .09 -.07 -.23 
     PRCS  .09 -.28 .03 .18 -.003 .01 .02 -.09 .24 
     SSPS-P    -.38* -.01 .08 .04 .09 .07 .07 -.15 
     SSPS-N    .38* -.23 -.32* -.21 -.45** -.45** -.01 
     STAI      -.46** -.45** -.05 -.49*** -.15 .04 
     QOLI      .47** .001 .58*** .22 .13 
     PHLMS- 
     Acceptance 
      -.22 .57*** .17 .06 
     PHLMS- 
     Awareness 
       -.02 .24 .07 
     AAQ-II         .50*** .19 
     DDS 
 
         .10 
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Table 17. Correlations Between Baseline Predictor Variables and Residualized Change  
Scores on Outcome Variables — Intent-to-Treat (Significant Correlations    
   Only) 
 
 
 
Process Variable  
(Baseline) 
Outcome Variable  
(Residualized Change Score) r p 
Overall Sample    
     AAQ-II STAI (mid-to-post change) -.39 .01 
     PHLMS-Acceptance STAI (mid-to-post change) -.32 .04 
     PHLMS-Awareness SSPS-Negative (mid-to-post change) -.30 .05 
      SSPS-Positive (mid-to-post change) .32 .03 
 SSPS-Positive (mid-to-follow-up change) .43 .01 
 SSPS-Positive (pre-to-post change) .43 .01 
      SSPS-Positive (pre-to-follow-up change) .52 .001 
ACT    
     AAQ-II QOLI (mid-to-post change) .44 .05 
     DDS STAI (pre-to-post change) -.52 .03 
 STAI (pre-to-follow-up change) -.61 .001 
     PHLMS-Acceptance PRCS (mid-to-post change) .45 .05 
     PHLMS-Awareness SSPS-Positive (pre-to-follow-up change) .47 .04 
Habituation    
     AAQ-II QOLI (pre-to-follow-up change) -.43 .04 
     PHLMS-Acceptance SSPS-Positive (mid-to-post change) -.43 .05 
     PHLMS-Awareness SSPS-Negative (pre-to-post change) -.44 .04 
 SSPS-Positive (mid-to-follow-up change) .43 .04 
 SSPS-Positive (pre-to-post change) .48 .02 
 SSPS-Positive (pre-to-follow-up change) .55 .01 
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Figure 1. Mean Scores on the Personal Report of Communication Apprehension (PRCA)   
        by Assessment Point and Treatment Condition. 
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Figure 2. Mean Scores on the Personal Report of Confidence as a Speaker (PRCS) by  
                Assessment Point and Treatment Condition. 
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Figure 3. Mean Scores on the Self-Statements During Public Speaking – Positive    
      Subscale (SSPS-Positive) by Assessment Point and Treatment Condition. 
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Figure 4. Mean Scores on the Self-Statements During Public Speaking – Negative    
      Subscale (SSPS-Negative) by Assessment Point and Treatment Condition. 
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Figure 5. Mean Peak Self-Reported Anxiety (Subjective Units of Discomfort; SUDS)   
                During BAT Speech by Assessment Point and Treatment Condition. 
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Figure 6. Mean Scores on the Drexel Defusion Scale (DDS) by Assessment Point and   
                Treatment Condition. 
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APPENDIX A: Treatment Protocols 
ACT Condition 
Session 1 
I. Complete BSQ (5 minutes)—as people come in. 
II. Brief introduction/overview (10 minutes) 
a. Thank you all for coming! Shows dedication, motivation, etc. and we 
appreciate the time commitment 
b. Intro/rapport building; quick overview of what will be done in today’s 
session: we will introduce ourselves, and explain the treatment model that will 
guide our sessions.  
c. Experiential practice will begin in session 2. We will be talking a lot during 
this first session because there is a lot to cover, but we want to involve you as 
much as possible. Please jump in with questions or comments at any time. 
There will be a lot more experiential participation starting in the next session. 
d. Treatment guidelines/procedures  
i. Attendance—it’s very important to attend all of the sessions if at all 
possible, but we understand that things come up and you might need to 
miss a session. If you miss a session, one of us will need to meet with 
you to “make up” the session (or touch base by phone if necessary) 
ii. Promptness –need to start on time so we can end on time—a lot to do 
in each session 
iii. Take-home exercises: 
1. Much of therapy takes place outside of sessions 
2. Importance of not using alcohol/drugs or PRN anxiety meds 
during HW exposures (and sessions) 
3. We won’t ask you to do anything you can’t do, and we will 
practice everything in session to whatever extent possible 
before we ask you to do it on your own 
iv. Confidentiality—everything is confidential; the only time we would 
break confidentiality is if there was any risk of harm to yourself or 
others, or if required by law (i.e., court subpoena) 
1. All of your information will be identified only by a subject 
number. Your name will be removed from all materials before 
the data are examined. 
2. We ask that anything personal discussed here, stays in this 
room. We want people to feel as comfortable as possible 
sharing information and practicing speaking situations. 
v. Importance of completing measures: Thank you so much for 
completing the online questionnaire. (This is the reason we are able to 
offer the free treatment, and this is how we know if our treatment is 
working and if we should continue to offer it to others). We will ask 
you to complete it again after the 3rd session and after the final session, 
and 6 weeks later (we will remind them). 
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vi. Medication changes—We ask that, if possible, you not modify the 
dosage of any psychiatric medications for the duration of the study. If 
there are any changes to your medication, please let us know. 
vii. Availability of therapist between sessions—give phone 
number/email address 
III. Icebreakers (10 minutes)—Before we get started, it’s important for us to start 
getting to know each other, since we will be meeting together for 6 weeks. 
a. Two Truths and a Lie—we’re going to ask each person to introduce 
themselves and make 3 statements about themselves—2 truths and 1 lie. Then 
the group will guess which statement is the lie. I know this may be difficult; 
after all, you’re coming here for help with public speaking, and we’re asking 
you to speak up in front of a group! But, it’s important, because we’ll be 
practicing some anxiety-provoking situations here, and we will need to 
establish a level of comfort with each other.  
i. Group leaders begin, then go around the room. After each person, have 
the group guess which statement is a lie. 
IV. Psychoeducation re: public speaking anxiety (5 min) 
a. Anxiety is a “fight or flight” response. This makes sense in the context of 
real, physical danger. Our ancestors survived because they were able to get 
anxious when confronted with danger (e.g., a tiger), which motivated them to 
fight or to get out of the situation. 
b. If you were to walk across the street and a bus was coming at you, you would 
experience strong anxiety that would motivate you to get out of the situation, 
and this would be seen as completely normal. 
c. In public speaking situations, even though we don’t necessarily need to fight 
or flee, the same response gets activated—the physiological arousal (increased 
heart rate, faster breathing, sweating, etc.). This is because it is a basic, 
primitive part of the brain that is responding to perceived threat. So, we 
understand that this is a real problem. 
V. Case examples (5 min)—although some people might consider public speaking 
anxiety to be a minor problem, we have been treating social anxiety/public 
speaking anxiety for a long time, and we have seen how severe it can be. 
a. In one of our cases, a woman we treated was working at a job where she was 
offered a promotion, and the new position would require her to provide 
supervision to 4-5 other employees, as well as run meetings. Although she had 
no problem providing supervision, she almost refused the promotion because 
she was afraid to lead meetings. 
b. Another woman we treated had recently moved to the area from out of state, 
and wanted to meet new people. She became involved with a social meet-up 
group that she discovered online, and was ok one-on-one, but she avoided 
becoming involved as an event planner for the group because she was anxious 
about introducing herself to the whole group at once. Eventually, over the 
course of therapy, she improved to the point where she not only led social 
events, but voluntarily gave toasts regularly to the whole group, often 20-30 
people or more.  
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c. So, we understand how much of a problem this can be. At the same time, we 
want to instill some hope in you that your anxiety in public speaking 
situations can be treated effectively. 
d. (If time—have each group member describe a recent public speaking situation 
in which they felt anxious) 
VI. Rationale for treatment: exposure in the context of acceptance/defusion (1 hour 
5 min total) 
a. “Creative hopelessness” (15 minutes) (write on board) 
i. Discuss how public speaking anxiety has limited or affected life 
ii. Discuss each person’s goals (what do you want to change in your life, 
regarding public speaking?), highlighting those involving anxiety 
reduction/ elimination, those involving enhanced functioning, and the 
relationship between these two categories (get at least one example 
from each person) 
iii. Elicit strategies for achieving goals, including how they have tried to 
cope with anxiety in public speaking situations (Get at least one 
example from each person) 
iv. Evaluate the usefulness of each strategy—how well has it worked? 
1. Most likely, not very well (otherwise they would not be in 
treatment) 
b. “Control as the problem” (5 minutes) 
i. When we feel anxious, what do we often do? (ask participants). 
Usually, we try to avoid the anxious feelings because they’re 
uncomfortable. A lot of the strategies that you have used (reference 
strategies written on the board—for example, avoiding the situation 
altogether, drinking alcohol, rushing through, trying to distract 
yourself.)  
ii. We’ve all seen how these strategies are generally ineffective in the 
long run (otherwise you would not be here). Maybe the problem is 
trying to control anxiety—not for lack of effort. Maybe these strategies 
CANNOT work 
iii. Chocolate cake metaphor: Whatever you do, don’t think about 
chocolate cake. Don’t think about the moist gooeyness of it, the smell 
of it baking in the oven. Don’t think about how warm it is and how 
good it tastes when you bite into it.  
1. What did you think about? (Chocolate cake) 
2. Did anyone not think about chocolate cake? (If so—how do 
you know you weren’t thinking about it? Because you thought 
about it) The more you try not to think about something, the 
more you think about it 
iv. Polygraph metaphor (shark tank): impossible to control anxious 
feelings, especially when stakes are high 
c. Alternative: Just noticing thoughts/feelings; acceptance/defusion (25 
minutes) 
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i. If controlling anxiety is not the answer, what might a possible 
alternative strategy look like? (Encourage participants to brainstorm 
ideas) 
ii. Introduce the idea of just noticing one’s thoughts and feelings, without 
trying to change them 
iii. Tug of War with Monster metaphor 
1. The struggle between you and your anxiety in public speaking 
situations is like being in a tug-of-war with a monster. Imagine 
that you are standing on one side of a cliff, and across from you 
is a monster—a big, hairy, scary monster that represents all of 
your anxiety. In between you and the monster is a bottomless 
ravine. You and the monster each hold one end of the rope and 
are pulling back and forth, each trying to pull the other into the 
ravine, but you never can quite pull the monster in (i.e., you 
can’t get rid of the anxiety). 
2. What is the alternative? The alternative to controlling anxiety 
is to “drop the rope” and allow the monster (anxiety) to exist, 
which frees you up to live according to your values and goals.  
Elicit pros/cons of this from participants (write on board) 
3. Price paid is that monster (anxiety) may never completely go 
away, and in fact is likely to show up from time-to-time.  
However, as long as the rope is dropped it cannot affect you 
one way or the other. 
4. Dropping the rope is not a single act, but rather a process that 
must be repeated on an ongoing basis. 
 
iv. Introduce Defusion: The process of defusion is the process of 
identifying thoughts and feelings as what they are rather than what 
they say they are. It’s the idea of stepping back from thoughts/feelings, 
seeing them as separate from the self—not necessarily the truth. 
1. Using a couple of little verbal conventions will help to 
undermine the tendency for words/thoughts to pull us into a 
struggle. 
2. Name the type of language being used by saying “I’m having 
the (thought/feeling/evaluation/bodily sensation) that….”  If 
you name the process, it’s easier to see what it really is, rather 
than what it just says it is. It’s also an important step in starting 
to be AWARE of your thoughts and feelings, and just notice 
them. 
3. Give an example of a thought related to public speaking and 
how to reformulate it. Example: “I’m going to mess up. 
Everyone can tell that I am sweating and shaking. I am so 
terrible at speaking to a group.” 
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a. Reformulate: “I’m having the thought that I will mess 
up. My body is experiencing sweating and trembling 
sensations, and I have the belief that others are aware of 
this. I am evaluating my public speaking skills as 
terrible.” 
b. Ask participants to give examples of thoughts they have 
had regarding public speaking, and to reformulate them 
(as a group). 
4. Can’t Pick Up the Pen: each group member will hold a pen in 
the palm of his or her hand, and will repeat the words “I can’t 
pick up the pen” several times while lifting the pen with the 
opposite hand, thus demonstrating that thoughts are not always 
true. 
a. Ask group members: How does this apply to thoughts 
about public speaking? (It’s the same with thoughts 
regarding public speaking—just because you think 
you’ll mess up, doesn’t mean you will.) 
v. Willingness: Discuss willingness to experience anxiety, and the act of 
being aware of and accepting one’s experiences in the service of 
achieving valued goals (tie-in to enhanced functioning goals from 
earlier) 
1. The idea of dropping the rope in the tug-of-war with the 
anxiety monster means that you are accepting that your anxiety 
will be there as a natural response. When you drop the rope, it 
means that you are WILLING to have anxiety. 
2. Apartment-Warming Party. Imagine that you just moved into a 
terrific new apartment and you decide to have an apartment-
warming party.  You decide to invite everyone, and you put out 
an open invitation.  You even put a sign on the door saying 
“Everyone Welcome.”  On the day of the party, everything is 
going perfectly.  Then there is a knock on the door and you see 
that it is Joe, your neighbor, who you find very annoying: he 
doesn’t dress well, he smells a little, and he makes very 
awkward conversation.  You are embarrassed to have him 
around.  So what can you do?  You can let him in but try to 
keep him trapped in the kitchen where no one will see him.  
You can tell him to go away, but you know he will keep 
coming back, so you will have to stand by the door guarding it 
(right under the “Everyone Welcome” sign.  Or you can 
welcome him to the party, let him in.  Can you see how you 
can fully accept his presence even if you don’t like him or the 
way he behaves.  …. So, how could this be a metaphor for 
being willing to let in feelings and thoughts and anxiety that 
you don’t like, in public speaking situations? 
d. Introduce concept of exposure (20 minutes) 
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i. Exposure = confronting situations that you fear (in this case, public 
speaking situations) 
ii. Reasons exposure is important? (elicit from participants) 
1. Opportunity to practice behavior while noticing 
thoughts/feelings (chance to practice willingness/acceptance) 
2. Promotes defusion from anxiety 
3. Allows us to practice valued behavior (public speaking) in a 
safe environment  
4. Allows us to work on social skills  (write on board, give social 
skills handout) 
a. Everyone can improve social skills 
b. Introduce areas of social skills 
i. Verbal (similar to transcript of TV show) 
ii. Nonverbal (watching a TV show with sound 
turned off) 
iii. Paralinguistic (watching TV show in a foreign 
language) 
iii. We’ve talked about what exposure is, and why it is important. But it is 
equally important to talk about what exposure is NOT. Exposure is 
NOT designed to reduce or eliminate anxiety.  In reality, anxiety 
reduction may (and often does, in fact) occur.  But, there are problems 
with anxiety reduction becoming the focus 
1. This paradox of experiential control (“if you’re not willing to 
have it, you’ve got it”—remember “chocolate cake”) 
2. Even if symptoms go away, they will almost certainly recur 
from time-to-time.  If you master the idea of accepting your 
experiences, this is not a problem, but if you focus on 
controlling your anxiety, this will be a big problem 
3. Not focusing on symptom control maximizes the ability to 
focus on what really matters in the long-term, i.e., behavior 
change 
iv. Concept of stepping outside of “comfort zone;” seeking out anxiety 
VII. Review key concepts (acceptance, defusion, willingness) (5 min) (write on 
board) 
a. As a way to help you remember what we just talked about, we have come up 
with a memory aid.  Use the word DAWN.  D-A-W-N, like the dawn of a new 
day or way of thinking about public speaking anxiety, using these strategies 
we’ve just taught you!   
b. D: Defusion/Distancing.  Step back from your thoughts and feelings about 
public speaking.  See them from a distance.  “I see myself having a feeling of 
anxiety right now.” 
c. A: Acceptance.  Whatever thoughts or feelings your mind creates are okay.   
d. W: Willingness.  Be willing to have what your mind gives you.  No matter 
how high your anxiety level is, you can let it be.  You don’t have to make it go 
away. 
  
105 
e. N: Noticing.  Become aware of what it is you are thinking and feeling in any 
given moment during a public speaking situation, without trying to push the 
thoughts and feelings away. 
f. The purpose of all of these strategies is to facilitate exposure—to help you to 
be willing to put yourself in public speaking situations even though you feel 
anxious 
VIII. Assign homework: (5 minutes) (hand out Take Home Points sheet, Sample Fear 
Hierarchy, Exposure Ideas, and First Session Monitoring Form) 
a. Give take-home message sheet 
b. Fear Hierarchy (give example sheet) 
i. You can use as many of these examples as you’d like, and also add 
your own that are personally relevant for you 
ii. List as many situations as you can, with the most difficult situations at 
the top, and the easiest at the bottom. 
c. Monitoring form:  
i. For any public speaking situations that come up: Note what strategies 
are used to cope with anxiety in public speaking situations 
1. Remember that public speaking doesn’t only include formal 
presentations—smaller-scale situations like talking in 
meetings/classes or addressing a group of friends or family are 
also examples of public speaking. 
ii. Note use of control strategies (including avoidance) and 
acceptance/defusion strategies 
d. Begin looking for ways to step outside of comfort zone – seeking out public 
speaking opportunities. We won’t assign any exposure exercises just yet, but 
start to look for ways to increase your public speaking opportunities. 
IX. Complete Reaction to Treatment Questionnaire (10 minutes) 
Session 2 
I. Complete BSQ (5 minutes)—as they come in 
II. Make copy of fear hierarchy (make sure name is on it) and give each person 
back their own—as they come in 
III. Briefly review homework (10 minutes)—ask people to volunteer examples 
a. Any situations that came up during the week--note use of both control and 
acceptance strategies.  
b. Review fear hierarchies briefly—ask each person to share a few situations 
from the top of their hierarchies 
IV. Review concepts from previous session (acceptance, willingness, defusion) 
(10 minutes) 
a. Ask participants how they feel about the ideas we discussed last time 
b. Use additional metaphors as needed (e.g., Two Scales (see Hayes et. al, 
1999)) 
V. Exposure exercises (1 hour 30 minutes total) 
a. As we mentioned last time, the exposure practice will begin in session 2, 
today. So, that’s what we’ll be focusing on today—each person will get a 
chance to practice a public speaking situation. 
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b. Briefly review rationale for exposure (ask participants to recall/summarize 
from previous session) 
i. Chance to practice willingness/acceptance/defusion 
ii. Opportunity to engage in valued behavior in a safe environment 
iii. Chance to work on social skills 
iv. Goal is NOT to reduce anxiety symptoms, but to behave 
consistently with one’s values 
c. For each participant--conduct exposure exercise (10 minutes per person).  
i. Introduce situation – come up with something in advance that you 
think would not be too difficult, then check with the participant to 
see if they are willing to do this exercise, or if they can think of 
something more relevant. Watch out for avoidance. Look at fear 
hierarchy --try to do something from the middle-low range of the 
fear hierarchy.  
ii. Establish behavioral goal for exposure exercise (e.g., remain in 
situation for 10 minutes; make at least 3 valid arguments in speech; 
solicit and answer 5 questions from audience) 
iii. Identify a social skill to be practiced during exposure exercise 
(e.g., eye contact, voice volume, posture, use of humor as 
appropriate); model as necessary.  
iv. Send the participant out of the room for approximately 30 seconds 
to 3 minutes while preparing the other group members to be 
confederates. Co-therapist can also be confederate, while primary 
therapist should remain in the therapist role. 
v. Bring participant back into the room. Reintroduce the situation and 
reiterate goal and social skill. 
vi. Encourage participants to do their best to notice their internal 
experience (i.e., thoughts/feelings/sensations) without judging, 
categorizing, or attempting to control it.  It is often helpful to frame 
willingness in terms of one of the metaphors/exercises that 
resonated with the participant, e.g., “remember to drop the rope…” 
vii. Intersperse metaphors/techniques throughout the exposures 
d. Discussion of how the exposure went (after each participant’s exposure) 
i. **Make sure to provide positive feedback for engaging in the 
exposure** 
ii. Did participant meet goal? 
iii. How well was the participant able to engage in willingness? 
iv. Feedback on the social skill(s) 
VI. Brief mindfulness meditation exercise: Leaves on a Stream (10 minutes) 
a. Now, with your permission, I would like to lead you through a brief 
mindfulness meditation exercise. The idea of mindfulness is to help you 
become aware of your thoughts and feelings without trying to change 
them or get rid of them. The goal of this exercise is not necessarily to 
relax, although that might happen. The point is just to notice your thoughts 
and feelings nonjudgmentally, and to get some practice allowing your 
thoughts just to be there. It’s a way to help you drop the rope. 
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First, I’d like to ask you to get in a comfortable position in your chair. Sit upright with 
your feet flat on the floor, your arms and legs uncrossed, and your hands resting in 
your lap, palms up or down, whichever is more comfortable. Allow your eyes to 
close gently [pause 10 seconds]. 
Take a few moments to get in touch with the physical sensations in your body, especially 
the sensations of touch or pressure where your body makes contact with the chair 
or floor [pause 10 seconds].  Take a moment to notice your breathing…notice the 
air flowing in through your nose, into your lungs….and back out again. 
It is okay for your mind to wander away to thoughts, worries, images, bodily sensations, 
or feelings. Notice these thoughts and feelings and acknowledge their presence. Just 
observe passively the flow of your thoughts, one after another, without trying to 
figure out their meaning or their relationship to one another. As best you can, 
bring an attitude of allowing and gentle acceptance to your experience. There is 
nothing to be fixed or changed. Simply allow your experience to be your experience 
[pause 15 seconds]. 
Now, please imagine sitting next to a stream [pause 10 seconds]. As you gaze at the 
stream, you notice a number of leaves on the surface of the water. Keep looking at 
the leaves and watch them slowly drift downstream [pause 15 seconds]. Every few 
moments, another leaf drifts down from the trees and lands in the water, then 
moves along down the stream. 
Now, when thoughts come along into your mind, put each one on a leaf, and observe as 
each leaf comes closer to you. Then watch it slowly moving away from you, 
eventually drifting out of sight. Return to gazing at the stream, waiting for the next 
leaf to float by with a new thought [pause 10 seconds]. If one comes along, again, 
watch it come closer to you and then let it drift out of sight. Think whatever 
thoughts you think and allow them to flow freely on each leaf, one by one. Imagine 
your thoughts floating by like leaves down a stream [pause 15 seconds]. 
You can also allow yourself to take the perspective of the stream. Being the stream, you 
hold each of the leaves and notice the thought that each leaf carries as it sails by. 
You need not interfere with them—just let them flow [pause 15 seconds]. 
Then, when you are ready, gradually widen your attention to take in the sounds around 
you in this room [pause 10 seconds]. Slowly return your attention to your 
breathing. [pause 10 seconds]. Take a moment to bring this sense of gentle allowing 
and self-acceptance into the present moment … and when you are ready, slowly 
open your eyes. 
b. Discuss group members’ experience with this exercise: Is anyone willing 
to share their experience with this exercise? … Were you able to just 
notice your thoughts, or did you try to change them? 
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VII. Assign homework (5 minutes) 
a. Write homework assignment on Behavioral Rx form and make copies 
before they leave (You may wish to do this ahead of time, particularly 
with a larger group) 
b. Exposure exercises, recorded on Monitoring Form (including amount of 
time spent engaging in exposure exercises) –make sure to use monitoring 
form that includes “time spent” column 
i. At least 3 exposure exercises per week—variations on theme 
practiced in session. Encourage them to do more if they can. 
c. Assign daily brief meditation practice (at least 1-2 minutes per day)—
record on Monitoring Form 
d. Distribute Mindfulness Meditation handout  
Session 3 
I. Complete BSQ (5 minutes)—as they come in 
II. Briefly review homework (10 minutes)—ask people to volunteer examples 
a. Did they practice their assigned exposure(s)? Any other exposures? 
b. Strategies used to handle the anxiety? (acceptance or control/avoidance?) 
c. Any barriers to completing the exposures? 
d. Collect homework 
III. Continue to review concepts from previous sessions (10 minutes) 
a. Use additional metaphors as needed  
b. The goal of willingness, acceptance, and defusion is not to “enjoy” the 
anxiety, or to “tolerate” it, but to help you move toward your valued 
goals—those action goals we talked about in the first session. Decrease 
avoidance 
c. Briefly review Mindfulness—ask how mindfulness practice went, and 
remind people that mindfulness does not necessarily need to be done in a 
formal, meditation context—one can mindfully wash the dishes, take a 
walk, etc.—The point is to notice your experiences nonjudgmentally and 
to be fully present in the moment 
IV. Exposure exercises (1 hour 30 minutes total) 
a. For each participant--conduct exposure exercise (10 minutes per person).  
i. Introduce situation – come up with something in advance from fear 
hierarchy, slightly more challenging than the previous week’s 
exposure, then check with the participant to see if they are willing 
to do this exercise, or if they can think of something more relevant. 
Watch out for avoidance.  
ii. Write situation, behavioral goal, and social skill on the board  
iii. Send the participant out of the room for approximately 30 seconds 
to 3 minutes while preparing the other group members to be 
confederates.  
iv. Bring participant back into the room. Reintroduce the situation and 
reiterate goal and social skill. 
v. Encourage participants to do their best to notice their internal 
experience (i.e., thoughts/feelings/sensations) without judging, 
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categorizing, or attempting to control it.  It is often helpful to frame 
willingness in terms of one of the metaphors/exercises that 
resonated with the participant, e.g., “remember to drop the rope…” 
vi. Intersperse metaphors/techniques throughout the exposures 
b. Discussion of how the exposure went (after each participant’s exposure) 
i. **Make sure to provide positive feedback for engaging in the 
exposure** 
ii. Did participant meet goal? 
iii. How well was the participant able to engage in willingness? 
iv. Feedback on the social skill(s) 
V. Assign homework (5 minutes) 
a. Assign exposures using Behavioral Rx form; make copies before they 
leave (again, you may wish to do this before the session) 
b. Exposure exercises and mindfulness practice recorded on Monitoring 
Form   
c. Remind them that they will be asked to complete the online questionnaire 
again before next session (send them the link after the session) 
 
Session 4 
VI. Complete BSQ (5 minutes) 
VII. Briefly review homework (10 minutes) 
VIII. Review concepts from previous sessions and introduce additional metaphors 
as needed (5-10 minutes) 
IX. Exposure exercises (1 hour 30 minutes total) – see Session 3 
X. Acceptance/defusion exercises and mindfulness meditation, chosen at 
discretion of therapists.  
a. Examples (see Hayes, Strosahl, & Wilson, 1999, for complete 
descriptions): 
i. Leaves on a Stream (mindfulness meditation)  
ii. Describe anxiety as an external object (defusion) 
iii. Dropping the rope (from Tug of War with Monster exercise) 
iv. Bubble in the Road (acceptance) 
v. Take Your Keys With You (acceptance) 
vi. FEAR/ACT acronyms (also see Eifert & Forsyth, 2005) 
vii. Content on Cards exercise 
viii. Other exercises as appropriate 
XI. Assign homework  (5 minutes) 
a. Assign exposures using Behavioral Rx form—at this point you may wish 
to have participants generate their own homework assignments 
b. Exposure exercises and mindfulness practice recorded on Monitoring 
Form   
c. Ask them to prepare a brief presentation (approximately 10 minutes; 
adjust up or down based on group size) for the next session on a topic of 
their choice. This may include PowerPoint, handouts, or any other 
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materials of their choosing, though this is not required. Explain that the 
idea is to allow them to practice something they have prepared, since up 
until now they have been doing impromptu speaking. Send email to 
clarify/remind prior to the next session. 
Session 5 
I. Complete BSQ (5 minutes)—as they come in 
II. Briefly review homework (10 minutes) 
III. Review concepts from previous sessions as needed (5 minutes) 
IV. Exposure exercises (1 hour 30 minutes total): Prepared presentations, 
followed by questions from the audience 
a. Discuss participant’s experience after each presentation, but do not 
interrupt during the presentation  
V. Assign homework (5 minutes) 
a. Assign exposures using Behavioral Rx form—at this point you may wish 
to have participants generate their own homework assignments 
b. Exposure exercises and mindfulness practice recorded on Monitoring 
Form   
a. Assign participants to construct a post-treatment plan (give sample). This 
does not need to be elaborate, nor will it be collected—it will simply be 
reviewed at the next session 
 
Session 6 
I. Complete BSQ (5 minutes)—as they come in 
II. Briefly review homework (10 minutes) 
III. Review progress, emphasizing positive gains 
a. Get an example from each person 
IV. Review concepts learned as needed—address questions, etc. 
V. Briefly review post-treatment plans-- ask people to volunteer examples, 
including things they still want to achieve 
VI. Psychoeducation re: lapse vs. relapse 
a. Explain that lapse is to be expected and is temporary, whereas complete 
relapse is rare 
b. Path up the Mountain Metaphor (Hayes et al., 1999): If you are hiking up 
a mountain, you may occasionally travel down “switchbacks” which take 
you back down the mountain a little, but overall you are making progress 
toward the top 
VII. Exposure exercises  
a. Allow participants to practice any additional situations they would like 
b. Karaoke (this can be done individually or in pairs/groups or with the 
therapists; although not required, participants should be strongly 
encouraged to sing as a chance to practice their skills and end treatment 
feeling successful) 
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VIII. Review post-treatment procedures: 
a. Remind them that they will be contacted by a research assistant within a 
couple of days to complete 15-minute phone assessment 
b. Reiterate importance of completing online questionnaire (email the link 
after session) 
c. Remind about 6-week follow-up assessment (phone assessment and online 
questionnaire) 
IX. Conduct post-treatment speech assessments with research assistants 
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Habituation Condition 
Session 1 
I. Complete BSQ (5 minutes)—as people come in. 
II. Brief introduction/overview (10 minutes) 
a. Thank you all for coming! Shows dedication, motivation etc. and we 
appreciate the time commitment 
b. Intro/rapport building; quick overview of what will be done in today’s 
session; we will introduce ourselves, and explain the treatment model that 
will guide our sessions.  
c. Experiential practice will begin in session 2. We will be talking a lot 
during this first session because there is a lot to cover, but we want to 
involve you as much as possible. Please jump in with questions or 
comments at any time. There will be a lot more experiential participation 
starting in the next session. 
d. Treatment guidelines/procedures  
i. Attendance—it’s very important to attend all of the sessions if at 
all possible, but we understand that things come up and you might 
need to miss a session. If you miss a session, one of us will need to 
meet with you to “make up” the session (or touch base by phone if 
necessary) 
ii. Promptness –need to start on time so we can end on time—a lot to 
do in each session 
iii. Take-home exercises: 
1. Much of therapy takes place outside of sessions 
2. Importance of not using alcohol/drugs or PRN anxiety 
meds during HW exposures (and sessions) 
3. We won’t ask you to do anything you can’t do, and we will 
practice everything in session to whatever extent possible 
before we ask you to do it on your own 
iv. Confidentiality—everything is confidential; the only time we 
would break confidentiality is if there was any risk of harm to 
yourself or others, or if required by law (i.e., court subpoena) 
1. All of your information will be identified only by a subject 
number. Your name will be removed from all materials 
before the data are examined. 
2. We ask that anything personal discussed here, stays in this 
room. We want people to feel as comfortable as possible 
sharing information and practicing speaking situations. 
v. Importance of completing measures: Thank you so much for 
completing the online questionnaire. (This is the reason we are 
able to offer the free treatment, and this is how we know if our 
treatment is working and if we should continue to offer it to 
others). We will ask you to complete it again after the 3rd session 
and after the final session, and 6 weeks later (we will remind them) 
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vi. Medication changes—We ask that, if possible, you not modify the 
dosage of any psychiatric medications for the duration of the study. 
If there are any changes to your medication, please let us know. 
vii. Availability of therapist between sessions—give phone 
number/email address 
III. Icebreakers (10 minutes)—Before we get started, it’s important for us to start 
getting to know each other, since we will be meeting together for 6 weeks. 
a. Two Truths and a Lie—we’re going to ask each person to introduce 
themselves and make 3 statements about themselves—2 truths and 1 lie. 
Then the group will guess which statement is the lie. I know this may be 
difficult; after all, you’re coming here for help with public speaking, and 
we’re asking you to speak up in front of a group! But, it’s important, 
because we’ll be practicing some anxiety-provoking situations here, and 
we will need to establish a level of comfort with each other.  
i. Group leaders begin, then go around the room. After each person, 
have the group guess which statement is a lie. 
IV. Psychoeducation re: public speaking anxiety (5 min) 
a. Anxiety is a “fight or flight” response. This makes sense in the context of 
real, physical danger. Our ancestors survived because they were able to 
get anxious when confronted with danger (e.g., a tiger), which motivated 
them to fight or to get out of the situation. 
b. If you were to walk across the street and a bus was coming at you, you 
would experience strong anxiety that would motivate you to get out of the 
situation, and this would be seen as completely normal. 
c. In public speaking situations, even though we don’t necessarily need to 
fight or flee, the same response gets activated—the physiological arousal 
(increased heart rate, faster breathing, sweating, etc.). This is because it is 
a basic, primitive part of the brain that is responding to perceived threat. 
So, we understand that this is a real problem. 
V. Case examples (5 min)—although some people might consider public 
speaking anxiety to be a minor problem, we have been treating social 
anxiety/public speaking anxiety for a long time, and we have seen how severe 
it can be.  
a. In one of our cases, a woman we treated was working at a job where she 
was offered a promotion, and the new position would require her to 
provide supervision to 4-5 other employees, as well as run meetings. 
Although she had no problem providing supervision, she almost refused 
the promotion because she was afraid to lead meetings. 
b. Another woman we treated had recently moved to the area from out of 
state, and wanted to meet new people. She became involved with a social 
meet-up group that she discovered online, and was ok one-on-one, but she 
avoided becoming involved as an event planner for the group because she 
was anxious about introducing herself to the whole group at once. 
Eventually, over the course of therapy, she improved to the point where 
she not only led social events, but voluntarily gave toasts regularly to the 
whole group, often 20-30 people or more.  
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c. So, we understand how much of a problem this can be. At the same time, 
we want to instill some hope in you that your anxiety in public speaking 
situations can be treated effectively. 
d. Would anyone be willing to share a public speaking situation in which 
they felt anxious? 
VI. Rationale for treatment: exposure in the context of habituation  
(1 hour 5 minutes total) 
a. Maintaining factors of anxiety (30 minutes) – illustrate these concepts on 
whiteboard while explaining  
i. Classical conditioning: Development of fear 
1. Basic concept: Unconditioned Stimulus (US) leads to 
Unconditioned Response (UR). Pairing a neutral stimulus 
(NS) with the US leads to UR; thus, neutral stimulus 
becomes Conditioned Stimulus (CS) and the response to 
this is a Conditioned Response (CR) 
a. Draw:  US  UR 
            US + NS  UR 
            NS becomes CS (through pairing with US) 
            CS  CR 
2. Application to public speaking: Once you start to 
experience anxiety symptoms (US) in public speaking 
situations (CS), you learn to associate all public speaking 
situations with anxiety. Also, if you have ever had a bad 
experience with public speaking, such as people laughing at 
you or telling you that you did a bad job, or if you saw 
someone else have a bad experience, this also becomes 
associated with public speaking situations. This can lead to 
the conditioned responses of fear and avoidance. 
a. Draw:  US (Physical symptoms of anxiety)  UR       
            (Fear and avoidance) 
            US + NS (Public speaking)  UR 
 NS (Public Speaking) becomes CS 
            CS (Public speaking)  CR (Fear and             
            avoidance) 
3. Ask group members to volunteer examples of early public 
speaking experiences where anxiety occurred 
ii. Operant conditioning: Maintenance of avoidance behavior 
1. Basic concept: negative reinforcement. When something 
unpleasant happens, and you find a way to decrease the 
unpleasant feelings, you tend to do that behavior more in 
the future—thus, it is reinforced. 
2. Application to public speaking: If you have anxiety in 
public speaking situations, what do you often do? You 
probably try to get out of the situation or avoid it 
altogether. What happens next? Your anxiety decreases, 
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which makes you more likely to avoid or escape these 
situations in the future. 
3. Ask group members for examples of what happens in 
public speaking situations (e.g., anxiety symptoms) and 
what happens to their anxiety when they leave or avoid a 
public speaking situation 
iii. Instruction on charting anxiety (including diagrams) 
1. Reintroduce concept of Subjective Units of Discomfort 
(SUDS) scale (participants should already be familiar with 
this from the pre-treatment assessment). Give SUDS scale 
handout to all group members.  
2. Illustrate what happens to anxiety in a public speaking 
situation (peak) and after leaving the situation (decrease). If 
possible, ask a group member to give a recent example (or 
return to an example someone gave) of a public speaking 
situation and chart that person’s actual SUDS levels. 
b. Discuss process of Habituation (15 minutes) 
i. Introduce concept: Habituation occurs when you expose yourself 
to a feeling (such as anxiety) for an extended period of time until 
the feeling decreases. It means that you are becoming desensitized 
to the feeling, so that it no longer affects you to the same degree. 
ii. By remaining in public speaking situation for an extended period 
of time (instead of avoiding or escaping), anxiety will eventually 
decrease, because you become used to it (or habituated to the 
feeling). The goal of this treatment is to help you become 
habituated to the feelings of anxiety in public speaking situations, 
so that these feelings will decrease in intensity.  
iii. Add additional chart next to previous one: What would happen to 
anxiety if you remained in the situation? (It would decrease). 
Return to previous participant example if possible. 
iv. Reasons that you have not habituated to anxiety in the past? You 
may not have stayed in the situation long enough, or done it often 
enough. Also, you might have used strategies to block the anxiety, 
such as medication, or trying to distract yourself from the anxiety 
instead of allowing yourself to fully experience it. 
c. Introduce concept of exposure (20 minutes)  
i. Exposure = confronting situations that you fear (in this case, public 
speaking situations) 
ii. Reasons exposure is important? (elicit from participants)  
1. Opportunity to practice maintaining behavior until anxiety 
decreases (habituation) 
2. Allows us to practice valued behavior (public speaking) in 
a safe environmentimprove skills, becomes easier 
3. Build successless likely to feel anxious and therefore less 
likely to avoid in the future (breaking the cycle of negative 
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reinforcement, and breaking the classically conditioned 
association between public speaking and feeling anxious) 
4. Allows us to work on social skills (write on board, give 
social skills handout) 
a. Everyone can improve social skills 
b. Introduce areas of social skills 
i. Verbal (similar to transcript of TV show) 
ii. Nonverbal (watching a TV show with sound 
turned off) 
iii. Paralinguistic (watching TV show in a 
foreign language) 
VII. Review key concepts (classical conditioning, operant conditioning, 
habituation) (write on board) 
a. As a way to help you remember what we just talked about, we have come 
up with a memory aid.  Use the word SPEACH (misspelled on purpose).  
S-P-E-A-C-H, like what you hope to be able to do, using the ideas we’ve 
been talking about!   
b. S: Social Skills. Remember to focus on the 3 areas of social skills: Verbal, 
Nonverbal, and Paralinguistic. 
c. P: Practice. The key to improving your skills in public speaking situations 
is to practice as much as possible! 
d. E: Exposure. Put yourself in public speaking situations and allow 
yourself to experience the anxiety. 
e. A: Anxiety. The goal of exposure is to remain in the feared situation until 
your anxiety decreases. 
f. C: Conditioning. Your anxiety and avoidance of public speaking 
situations is being maintained through the processes of conditioning, so 
it’s important to experience anxiety in these situations to undo the 
conditioning. 
g. H: Habituation. By continually exposing yourself to anxiety in public 
speaking situations, you will eventually become used to the feeling so that 
it will not affect you to the same extent, if at all. 
VIII. Assign homework: (5 minutes) (hand out Take Home Points sheet, Sample 
Fear Hierarchy, Exposure Ideas, and First Session Monitoring Form) 
a. Give take-home message sheet 
b. Fear Hierarchy (give example sheet) 
i. You can use as many of these examples as you’d like, and also add 
your own that are personally relevant for you 
ii. List as many situations as you can, with the most difficult 
situations at the top, and the easiest at the bottom. 
c. Monitoring form:  
i. For any public speaking situations that come up: Monitor anxiety 
levels (SUDS ratings—before, after, highest)  
1. Remember that public speaking doesn’t only include 
formal presentations—smaller-scale situations like talking 
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in meetings/classes or addressing a group of friends or 
family are also examples of public speaking. 
d. Begin looking for ways to step outside of comfort zone – seeking out 
public speaking opportunities. We won’t assign any exposure exercises 
just yet, but start to look for ways to increase your public speaking 
opportunities. 
IX. Complete Reaction to Treatment Questionnaire (10 minutes)—hand out and 
ask them to complete before leaving. 
Session 2 
I. Complete BSQ (5 minutes)—as they come in 
II. Make copy of fear hierarchy (make sure name is on it) and give each person 
back their own—as they come in 
III. Briefly review homework (10 minutes)—ask people to volunteer examples 
a. Any situations that came up during the week--note changes in anxiety and 
operant/classical conditioning principles.  
b. Also note any use of safety behaviors that may have prohibited the 
participant from habituating to anxiety—avoiding/escaping situations, 
using medication, alcohol, etc.  
c. Review fear hierarchies briefly—ask each person to share a few situations 
from the top of their hierarchies 
IV. Review concepts from previous session (habituation, classical/operant 
conditioning, SUDS) (10 minutes) 
a. Ask participants how they feel about the ideas we discussed last time 
b. Review and draw diagrams as needed 
V. Exposure exercises (1 hour 30 minutes total) 
a. As we mentioned last time, the exposure practice will begin in session 2, 
today. So, that’s what we’ll be focusing on today—each person will get a 
chance to practice a public speaking situation. 
b. Briefly review rationale for exposure (ask participants to recall/summarize 
from previous session) 
i. Chance to break negative reinforcement cycle (decreasing anxiety 
by avoiding/escaping public speaking situations) 
ii. Opportunity to build skills in a safe environment 
iii. Chance to work on social skills 
iv. Goal is to REDUCE anxiety by remaining in the feared situation 
until you become habituated to the feelings of anxiety 
c. For each participant--conduct exposure exercise (10 minutes per person).  
i. Introduce situation – come up with something in advance that you 
think would not be too difficult, then check with the participant to 
see if they are willing to do this exercise, or if they can think of 
something more relevant. Watch out for avoidance. Look at fear 
hierarchy --try to do something from the middle-low range of the 
fear hierarchy.  
  
118 
ii. Establish behavioral goal for exposure exercise (e.g., remain in 
situation for 10 minutes; make at least 3 valid arguments in speech; 
solicit and answer 5 questions from audience) 
iii. Identify a social skill to be practiced during exposure exercise 
(e.g., eye contact, voice volume, posture, use of humor as 
appropriate); model as necessary.  
iv. Send the participant out of the room for approximately 30 seconds 
to 3 minutes while preparing the other group members to be 
confederates. Co-therapist can also be confederate, while primary 
therapist should remain in the therapist role. 
v. Bring participant back into the room. Reintroduce the situation and 
reiterate goal and social skill. 
vi. Encourage participants to remain in the situation until their anxiety 
begins to decrease 
vii. Get initial SUDS rating and chart it on the board 
viii. Stop the participant every minute or so to get a SUDS rating 
d. Discussion of how the exposure went (after each participant’s exposure) 
i. **Make sure to provide positive feedback for engaging in the 
exposure** 
ii. What is your SUDS rating now? What was the highest it got to? 
(Chart on board, pointing out the pattern that it may increase 
initially, then decrease) 
iii. Did participant meet goal? 
iv. Did anxiety decrease? 
v. Feedback on the social skill(s) 
VI. Assign homework (5 minutes) 
a. Write homework assignment on Behavioral Rx form and make copies 
before they leave (in a larger group, you may want to do this before the 
session) 
b. Exposure exercises, recorded on Monitoring Form (including amount of 
time spent engaging in exposure exercises) – use the monitoring form with 
graphs attached; explain graphing 
i. At least 3 exposure exercises per week—variations on theme 
practiced in session. Encourage them to do more if they can. 
c. Chart SUDS ratings for each exposure exercise (before, after, highest 
point) 
Session 3 
II. Complete BSQ (5 minutes)—as they come in 
III. Briefly review homework (10 minutes)—ask people to volunteer examples 
a. Did they practice their assigned exposure(s)? Any other exposures? 
b. Discuss what happened with their SUDS levels  
c. Any barriers to completing the exposures? 
d. Collect homework—make sure names are on them 
IV. Review concepts from previous sessions as needed (habituation, 
classical/operant conditioning, SUDS) (5 minutes) 
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V. Exposure exercises (1 hour 30 minutes total) 
a. For each participant--conduct exposure exercise (10 minutes per person).  
i. Introduce situation – come up with something in advance from fear 
hierarchy, slightly more challenging than the previous week’s 
exposure, then check with the participant to see if they are willing 
to do this exercise, or if they can think of something more relevant. 
Watch out for avoidance.  
ii. Write situation, behavioral goal, and social skill on the board  
iii. Send the participant out of the room for approximately 30 seconds 
to 3 minutes while preparing the other group members to be 
confederates.  
iv. Bring participant back into the room. Reintroduce the situation and 
reiterate goal and social skill. 
v. Encourage participants to remain in the situation until their anxiety 
begins to decrease 
vi. Get initial SUDS rating and chart it on the board 
vii. Have them give a signal (e.g., raise hand) when anxiety starts to 
decrease (the idea is to fade the prompting for SUDS ratings over 
subsequent sessions) 
b. Discussion of how the exposure went (after each participant’s exposure) 
i. **Make sure to provide positive feedback for engaging in the 
exposure** 
ii. What is your SUDS rating now? What was the highest it got to? 
(Chart on board, pointing out the pattern that it may increase 
initially, then decrease) 
iii. Did participant meet goal? 
iv. Did anxiety decrease? 
v. Feedback on the social skill(s) 
VI. Assign homework (5 minutes) 
a. Assign exposures using Behavioral Rx form, make copies before they 
leave (again, you may wish to do this prior to the session) 
b. Exposure exercises and SUDS levels recorded on Monitoring Form   
c. Remind them that they will be asked to complete the online questionnaire 
again before next session (send them the link after the session) 
Session 4 
VI. Complete BSQ (5 minutes)—as they come in 
VII. Briefly review homework (10 minutes). Thank everyone for completing the 
mid-treatment questionnaire. 
VIII. Review concepts from previous sessions as needed (5 minutes) 
IX. Exposure exercises (1 hour 30 minutes total) (see session 3) 
X. Assign homework (5 minutes) 
a. Assign exposures using Behavioral Rx form—at this point you may wish 
to have participants generate their own homework assignments 
b. Exposure exercises and SUDS levels recorded on Monitoring Form   
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c. Ask them to prepare a brief presentation (approximately 10 minutes; 
adjust up or down based on group size) for the next session on a topic of 
their choice. This may include PowerPoint, handouts, or any other 
materials of their choosing, though this is not required. Explain that the 
idea is to allow them to practice something they have prepared, since up 
until now they have been doing impromptu speaking. Send email to 
clarify/remind prior to the next session. 
 
Session 5 
XI. Complete BSQ (5 minutes)—as they come in 
XII. Briefly review homework (10 minutes) 
XIII. Review concepts from previous sessions as needed (5 minutes) 
XIV. Exposure exercises (1 hour 30 minutes total): Prepared presentations, 
followed by questions from the audience 
a. Discuss SUDS levels after each presentation, but do not interrupt during 
the presentation to ask for ratings 
XV. Assign homework (5 minutes) 
a. Assign exposures using Behavioral Rx form—at this point you may wish 
to have participants generate their own homework assignments 
b. Exposure exercises and SUDS levels recorded on Monitoring Form   
d. Assign participants to construct a post-treatment plan (give sample). This 
does not need to be elaborate, nor will it be collected—it will simply be 
reviewed at the next session 
Session 6 
VIII. Complete BSQ (5 minutes)—as they come in 
IX. Briefly review homework (10 minutes) 
X. Review progress, emphasizing positive gains 
a. Get an example from each person 
XI. Review concepts learned as needed—address questions, etc. 
XII. Briefly review post-treatment plans-- ask people to volunteer examples, 
including things they still want to achieve 
XIII. Psychoeducation re: lapse vs. relapse 
a. Explain that lapse is to be expected and is temporary, whereas complete 
relapse is rare 
XIV. Exposure exercises  
a. Allow participants to practice any additional situations they would like 
b. Karaoke (this can be done individually or in pairs/groups or with the 
therapists; although not required, participants should be strongly 
encouraged to sing as a chance to practice their skills and end treatment 
feeling successful) 
XV. Review post-treatment procedures: 
a. Remind them that they will be contacted by a research assistant within a 
couple of days to complete 15-minute phone assessment 
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b. Reiterate importance of completing online questionnaire (email the link 
after session) 
c. Remind about 6-week follow-up assessment (phone assessment and online 
questionnaire) 
XVI. Conduct post-treatment speech assessments with research assistants 
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APPENDIX B: Personal Report of Communication Apprehension (PRCA-24) 
Public Speaking Subscale 
 
 
 
 
DIRECTIONS:  This instrument is composed of 6 statements concerning your feelings 
about public speaking.  Please indicate the degree to which each statement applies to you 
by marking whether you (1) strongly agree, (2) agree, (3) are undecided, (4) disagree, or 
(5) strongly disagree.  Work quickly; record your first impression.  
 
 
_____ 1. I have no fear of giving a speech.  
 
_____ 2. Certain parts of my body feel very tense and rigid while I am giving a speech.  
 
_____ 3. I feel relaxed while giving a speech.  
 
_____ 4. My thoughts become confused and jumbled when I am giving a speech.  
 
_____ 5. I face the prospect of giving a speech with confidence.  
 
_____ 6. When giving a speech, I get so nervous I forget facts I really know.  
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APPENDIX C: Personal Report of Confidence as a Speaker – Short Form 
 
 
Instructions: This instrument is composed of 12 items regarding your feelings of 
confidence as a speaker. Decide whether “true” or “false” most represents your feelings 
associated with public speaking. Work quickly and don’t spend too much time on any 
one question; we want your first impression. 
 
1. My hands tremble when I try to handle objects on the platform 
2. I am in constant fear of forgetting my speech 
3. While preparing a speech I am in a constant state of anxiety 
4. My thoughts become confused and jumbled when I speak before an audience 
5. Although I talk fluently with friends I am at a loss for words on the platform 
6. The faces of my audience are blurred when I look at them 
7. I feel disgusted with myself after trying to address a group of people 
8. I perspire and tremble just before getting up to speak 
9. My posture feels strained and unnatural 
10. I am fearful and tense all the while I am speaking before a group of people 
11. It is difficult for me to search my mind calmly for the right words to express my 
thoughts 
12. I am terrified at the thought of speaking before a group of people 
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APPENDIX D: Self-Statements During Public Speaking (SSPS) 
 
Please imagine what you have typically felt and thought to yourself during any kind of 
public speaking situations.  Imagining these situations, how much do you agree with the 
statements given below.  Please rate the degree of your agreement on a scale between 0 
(if you do not agree at all) to 5 (if you agree extremely with the statement).  
 
1. What do I have to lose; it’s worth a try  
2. I’m a loser  
3. This is an awkward situation but I can handle it  
4. A failure in this situation would be more proof of my incapacity  
5. Even if things don’t go well, it’s no catastrophe  
6. I can handle everything  
7. What I say will probably sound stupid  
8. I’ll probably “bomb out” anyway  
9. Instead of worrying I could concentrate on what I want to say  
10. I feel awkward and dumb; they’re bound to notice  
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APPENDIX E: State-Trait Anxiety Inventory (STAI): A-State 
 
 
 
 
Read each statement and select the appropriate response to indicate how you feel right 
now, that is, at this very moment. There are no right or wrong answers. Do not spend 
too much time on any one statement but give the answer which seems to describe your 
present feelings best. 
 
 
Response Categories 
 
   1. Not at all 
   2. A little 
   3. Somewhat 
   4. Very Much So  
 
 
 
   1. I feel calm 
   2. I feel secure 
   3. I feel tense 
   4. I feel strained 
   5. I feel at ease 
   6. I feel upset 
   7. I am presently worrying over possible misfortunes 
   8. I feel satisfied 
   9. I feel frightened 
  10. I feel uncomfortable 
  11. I feel self-confident 
  12. I feel nervous 
  13. I feel jittery 
  14. I feel indecisive 
  15. I am relaxed 
  16. I feel content 
  17. I am worried 
  18. I feel confused 
  19. I feel steady 
  20. I feel pleasant  
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APPENDIX F: Philadelphia Mindfulness Scale (PHLMS)   
Instructions:  Please indicate how often you experienced each of the following statements 
within the past week.    
     1         2            3              4            5  
Never Rarely Sometimes Often Very Often  
 
1.  I am aware of what thoughts are passing through my mind.  
2.  I try to distract myself when I feel unpleasant emotions.  
3.  When talking with other people, I am aware of their facial and body expressions.  
4.  There are aspects of myself I don’t want to think about.  
5.  When I shower, I am aware of how the water is running over my body.  
6.  I try to stay busy to keep thoughts or feelings from coming to mind.  
7.  When I am startled, I notice what is going on inside my body.  
8.  I wish I could control my emotions more easily.  
9.  When I walk outside, I am aware of smells or how the air feels against my face.  
10.  I tell myself that I shouldn’t have certain thoughts.  
11.  When someone asks how I am feeling, I can identify my emotions easily.  
12.  There are things I try not to think about.  
13.  I am aware of thoughts I’m having when my mood changes.  
14.  I tell myself that I shouldn’t feel sad.  
15.  I notice changes inside my body, like my heart beating faster or my muscles getting 
tense.  
16.  If there is something I don’t want to think about, I’ll try many things to get it out of 
my mind.  
17.  Whenever my emotions change, I am conscious of them immediately.  
18.  I try to put my problems out of mind.  
19.  When talking with other people, I am aware of the emotions I am experiencing.  
20.  When I have a bad memory, I try to distract myself to make it go away.  
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APPENDIX G: Drexel Defusion Scale 
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APPENDIX H: Acceptance and Action Questionnaire – II 
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APPENDIX I: Quality of Life Inventory (QOLI) 
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APPENDIX J: Before-Session Questionnaire (BSQ) 
                                                                                                                                             
Your Name: _____________________________         Today’s Date: ______________       
 
The following questions ask about how things have been going for you over the past week.  Please 
read each statement carefully, and then make a rating on the scale provided as to how much the 
statement applies to you over the past week. 
 
 
 
 
 
 
 
1 
Overall, I would rate my general sense 
of well-being over the past week as... 
 1 2 3 4 5 6 7 
 Very good   Okay   Very poor 
 
2 
When I consider my psychological and 
emotional state, I would say I am... 
 1 2 3 4 5 6  7  
 Doing   Doing   Doing  
 exceptionally well   okay   very poorly 
3 
In terms of my overall satisfaction with 
my life, I am... 
 1 2 3 4 5 6 7  
Perfectly satisfied   Somewhat   Not at all 
    satisfied   satisfied 
4 
In terms of my overall satisfaction with 
my school/work life, I am... 
 1 2 3 4 5 6 7  
 Perfectly satisfied   Somewhat   Not at all 
    satisfied   satisfied 
5 
In terms of my overall satisfaction with 
my romantic life, I am... 
 1 2 3 4 5 6 7  
 Perfectly satisfied   Somewhat   Not at all 
    satisfied   satisfied 
6 
The frequency and intensity of my 
specific symptoms or problems over the 
past week has been... 
 1 2 3 4 5 6 7 
 Very low   Average   Very high  
 
7 
The amount of distress I have 
experienced from my symptoms or 
problems over the past week has been... 
 1 2 3 4 5 6 7 
 Very low   Medium   Very high 
8 
In terms of overall level of depression, 
this week I have felt... 
 1 2 3 4 5 6 7 
 Not very   Somewhat   Extremely 
 depressed   depressed   depressed 
9 
In terms of overall level of anxiety, this 
week I have felt... 
 1 2 3 4 5 6 7 
 Not very   Somewhat   Extremely 
 anxious   anxious   anxious 
10 
In considering my most important goals, 
I would rate my progress toward my 
goals over the past week as... 
 1 2 3 4 5 6 7 
A lot of progress   Some progress    Little progress 
11 
Whenever I had bothersome thoughts 
over the past week, I tended to... 
 1 2 3 4 5 6 7 
Just notice them without      Try to change 
 trying to change them      or get rid of them 
12 
Whenever I had bothersome feelings 
over the past week, I tended to... 
 1 2 3 4 5 6 7 
Just notice them without      Try to change 
 trying to change them      or get rid of them 
13 My thoughts tend to be... 
 1 2 3 4 5 6 7 
 Unrealistically   Fairly accurate   Unrealistically  
 positive      negative 
14 
When I have thoughts that I “know” 
are unrealistically negative... 
 1 2 3 4 5 6 7 
I’m able to see them as just I can’t help but take 
thoughts and not as the truth them as the truth 
15 
In terms of the effect of my emotions on 
my behavior, my anxiety, depression 
and other distress... 
 1 2 3 4 5 6 7 
Does not prevent me   Keeps me from doing   Prevents me from 
from doing anything   some important   doing many 
of importance   things   important things 
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APPENDIX K: Reaction to Treatment Questionnaire 
 
On a scale of 1 (low) to 10 (high), please rate your reaction to your experience of 
treatment so far.  Indicate your rating by circling the appropriate number. 
 
1. How logical does this type of treatment seem to you? 
 
1 2 3 4 5 6 7 8 9        10 
Not                 Very  
Logical                           Logical 
 
2. How confident are you that this treatment will be successful in eliminating your 
fear of public speaking? 
 
1 2 3 4 5 6 7 8 9        10 
Not at all                Very  
Confident                           Confident 
 
3. How confident would you be in recommending this treatment to a friend who was 
extremely anxious about public speaking? 
 
1 2 3 4 5 6 7 8 9        10 
Not at all                Very  
confident                           confident 
 
4. How successful do you feel this treatment would be in decreasing different fears? 
 
1 2 3 4 5 6 7 8 9        10 
Not at all                Very  
successful                           successful 
 
5. How confident are you that this treatment could eliminate fear of giving a speech? 
 
1 2 3 4 5 6 7 8 9        10 
Not at all                Very  
confident                           confident 
 
6. How severe is your fear of public speaking now? 
 
1 2 3 4 5 6 7 8 9        10 
Not at all                Very        
severe                 severe 
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7. How severe do you expect your fear of public speaking to be immediately 
following treatment? 
 
1 2 3 4 5 6 7 8 9        10 
Not at all                Very        
severe                 severe 
 
8. How severe do you expect your fear of public speaking to be: 
 
a. One year after treatment? 
 
1 2 3 4 5 6 7 8 9        10 
Not at all                Very        
severe                 severe 
 
b. Five years after treatment? 
 
1 2 3 4 5 6 7 8 9        10 
Not at all                Very        
severe                 severe 
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APPENDIX L: Demographics Questionnaire 
 
Age: _______   Year of Birth: __________________  
Gender (circle one):   Male    or    Female 
 
Employment status: 
   (0)   full-time              (1)   part-time       (2)   occasional/per diem        
   (3)   disability/SSI       (4)  no income 
 
Occupation:_____________________________ 
 
Student status (if applicable): 
(0)   full-time        (1)   part-time 
 
Student type (if applicable): 
(0)   undergraduate (1)   graduate 
 
Marital/relationship status: 
   (0)   single (no current romantic partner)        
   (1)   married         
   (2)   living with partner (not married) 
   (3)   not living with current partner 
   (4)   divorced 
   (5)   widowed 
 
 
 
  
134 
Ethnicity (check all that apply): 
 (0)  African American / Black 
 (1)  Caribbean / Haitian 
 (2)  African 
 (3)  Asian American 
 (4)  Asian / Pacific-Islander 
 (5)  White / European American / Caucasian 
 (6)  European 
 (7)  Latino/Latina / Hispanic American / Hispanic 
 (8)  Native American / American Indian 
 (9)  Multiracial 
 (10)  Other:  
 
 
 
Is English your first language? 
 (0)  Yes  
 (1)  No; I learned starting at age:  
 
Have you been in counseling/therapy before? If so, please indicate date(s) and a brief 
description of treatment (including reason for treatment). Also indicate any medications 
you have taken (including dates) for mental health reasons. 
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________ 
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APPENDIX M: Treatment Handouts/Worksheets 
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Drexel Public Speaking Anxiety Study 
Behavioral Rx 
 
Name: _________________________________ 
 
Date: __________________________________ 
Assignment: 
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________ 
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Social Skills Types 
 
1. Verbal – the content of what you are saying (like the transcript of a TV show) 
a. Your prepared speech 
b. Asking a question 
c. Giving your opinion 
d. Addressing your audience 
 
2. Nonverbal – what you do; body language (like watching a TV show with no 
sound) 
a. Eye contact 
b. Posture 
c. Gestures/hand movements 
 
3. Paralinguistic – qualities of speech other than content (like watching a TV show 
in a foreign language) 
a. Voice volume 
b. Rate/speed of speech 
c. Tone/pitch 
d. Articulation 
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Public Speaking Exposure Exercises  
(adapted from Monarth & Kase, 2007) 
 
Exposure Exercises Involving Speaking Up In Meetings/Classes: 
1. Offer to present weekly statistics or reports to the group. 
2. Introduce a new member, guest, or client. 
3. Ask 2-3 questions per meeting. 
4. Answer 2-3 questions per meeting. 
5. Offer to be the meeting facilitator. 
6. In a small class, make 3-5 comments. In a larger class, make 1-2 comments. 
7. Volunteer to present a summary of your current work or projects. 
8. Make 2-3 follow-up comments on a point one of your colleagues/classmates has 
made. 
9. Offer a new or original viewpoint. 
10. Say something to present the opposite side of a situation. Respectfully disagree 
with a colleague or classmate. For a greater challenge, practice disagreeing with a 
person whom you find intimidating. 
11. Direct questions toward the people who make you nervous during meetings. 
 
Exposure Exercises Involving Giving Presentations/Workshops: 
 
1. Create a 10-minute interactive presentation on any topic and present it to some of 
your friends or family members. 
2. Develop a short workshop or training on a topic of interest to your 
colleagues/classmates. Then tell your supervisor/professor that you would like to 
present it to your colleagues/classmates. 
3. Take a class that involves opportunities to speak and give presentations. 
4. If you know you have a presentation coming up, practice presenting it to a group 
of friends/family. 
5. Practice teaching things you know to others in a group. Have them ask you 
questions, then answer them. 
6. Give a topic to a group of friends or family members and ask them to grill you on 
it for five minutes (or more), asking as many questions as possible. 
 
Exposure Exercises Involving Being Called Upon/Put On The Spot: 
 
1. Get together a group of questions, such as from a game like Trivial Pursuit. Ask a 
group of friends or family members to pick one of the questions and talk about it 
for 3 minutes (without telling you the question). After 3 minutes, have them ask 
you the question. This will make you follow a brief discussion and answer a 
question that you may not know the answer to. 
2. For a modification of the above exercise, have the group members take turns 
asking each other the questions. This way, you won’t know when you will be 
called on. 
3. Raise your hand in classes/meetings. Volunteer to answer questions as much as 
possible. 
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4. Tell people to call on you. Let your colleagues and supervisors/professors know 
that you’re trying to perfect your skills at thinking on your feet, so you’d like 
them to call on you whenever possible. Practice making eye contact during every 
discussion, knowing that at any moment you could be called on. 
 
Exposure Exercises Involving Answering Questions Following a Speech: 
 
1. Every time you talk, ask people if they have any questions. 
2. Offer to mediate a conflict at work. 
3. Raise a controversial topic with friends/family, or in a meeting or class. 
4. Ask questions yourself and observe how the speakers respond. Use their good 
ways of responding as a role model for how you would like to appear. 
 
Exposure Exercises Involving Speaking Up in Group Situations: 
 
1. Give a toast at a gathering of family or friends. 
2. Host a dinner or cocktail party and make announcements or a toast to the whole 
group. 
3. Go out to lunch or other informal social gatherings with colleagues, including 
those who make you nervous or intimated, and join in the group conversation. 
4. Go to a Toastmasters meeting. Visit www.toastmasters.org to find a group near 
you. 
5. Join a book club or other activity group where each member has an opportunity to 
speak. 
 
Exposure Exercises Involving Awkward Situations: 
 
1. In a group setting, make a minor blunder—for example, spill something on your 
shirt, intentionally mispronounce a word or “forget” someone’s name, drop 
something, or trip. 
2. Admit when you don’t know the answer to a question. 
3. Pick some times when you don’t have something specific to say and choose to ask 
some questions. Ask someone to clarify a point, or ask your audience for an idea 
or comment. 
 
Exposure Exercises Involving Performance Situations: 
 
1. Get together with friends and sing karaoke songs at someone’s home. 
2. Go to a bar or restaurant that offers karaoke and sing a song – without alcohol! 
a. To make this harder—try to mess up the song on purpose! 
3. Go to an open mic night at a comedy club and take a turn on stage. 
4. If you sing or play an instrument, practice doing so in front of a group of friends 
or family. 
5. Play Charades or a similar game with friends. 
6. Go to a park or other public place and sing a song or make up a speech. 
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Public Speaking Anxiety: First Session Take-Home Points [ACT] 
 Remember that no matter how hard one tries, there is no way to control thoughts—
you have seen how this does not work. Therefore, the alternative is to learn how to 
focus on your public speaking task while still feeling anxiety. 
 
 Be aware of when you are losing focus on the public speaking situation and 
becoming entangled with your anxiety. 
 
 DAWN: Defusion, Acceptance, Willingness, Noticing 
 
 Defuse, or recognize that your thoughts are just thoughts.  This involves recognizing 
that we can feel anxious, yet we can control our body to continue focusing on the 
public speaking task at hand. 
o Defusion examples: 
 Thank your mind for having a thought, and continue with whatever 
you were doing. 
 Welcome your thought as a familiar, though irritating, friend (like 
“Joe” the annoying neighbor). 
 Add the stem “I’m having the thought/feeling that” in front of your 
thoughts/feelings. 
 Realizing that having a thought does not make it true. 
 Turn your “but” statements into “and” statements—instead of saying 
“I want to do well on my presentation, but I’m really nervous,” try 
saying “I want to do well on my presentation, AND I’m really 
nervous.” This makes both things possible at the same time. 
 
 Practice adopting an accepting attitude towards feelings/thoughts; experience them 
non-judgmentally, without trying to make them change or go away. 
 “No matter how strong my anxiety gets, I’m just going to let it be in 
my head.  I don’t need to make it go away.” 
 “I can have the anxiety and still give a presentation.” 
 “I can have the anxiety and still speak during my meeting.” 
 “I can have the anxiety and still give a toast.” 
 
 Try to be willing to feel anxiety during public speaking situations rather than 
struggling with it, which will only divert your attention from the task at hand.  Drop 
the rope! 
 
 Whenever you notice that you have lost focus on the current public speaking task, 
take a moment to notice any thoughts and feelings you have, and gently refocus your 
attention on what you were saying. 
 
 These techniques are designed to promote exposure: the idea of putting yourself in 
feared public speaking situations. Exposure can help you to notice and accept your 
thoughts and feelings without trying to change them. Simultaneously, exposure 
allows you to practice important social skills while working toward your valued 
public speaking goals.  
 
  
141 
Public Speaking Anxiety: First Session Take-Home Points [Habituation] 
 
 SPEACH: Social Skills, Practice, Exposure, Conditioning, Habituation 
 
o S: Social Skills. Remember to focus on the 3 areas of social skills: Verbal, 
Nonverbal, and Paralinguistic. 
 
o P: Practice. The key to improving your skills in public speaking situations 
is to practice as much as possible! 
 
o E: Exposure. Put yourself in public speaking situations and allow 
yourself to experience the anxiety. 
 
o A: Anxiety. The goal of exposure is to remain in the feared situation until 
your anxiety decreases. 
 
o C: Conditioning. Your anxiety and avoidance of public speaking 
situations is being maintained through the processes of conditioning, so 
it’s important to experience anxiety in these situations to undo the 
conditioning. 
 
o H: Habituation. By continually exposing yourself to anxiety in public 
speaking situations, you will eventually become used to the feeling so that 
it will not affect you to the same extent, if at all. 
 
 
 When you avoid or escape from a public speaking situation, your anxiety 
decreases, which reinforces the avoidance behavior. That is why it’s important to 
remain in the situation until your anxiety level decreases, instead of allowing 
yourself to escape from the situation. 
 
 Exposure to feared public speaking situations can help you to habituate to the 
feelings of anxiety, which will in turn help you to feel less anxious in these 
situations in the future. Simultaneously, exposure allows you to practice important 
social skills while working toward your valued public speaking goals.  
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Post-Treatment Plan Instructions [ACT] 
• Even though you have completed the treatment, it is important that you keep 
thinking about the goals discussed during treatment and what you still want to 
accomplish with regard to public speaking. 
• The best way to keep doing this is to list specific goals and how you will meet 
them using the skills learned in the treatment group. 
• It is important to break down bigger goals (long-term goals) into the specific steps 
or subgoals (short-term goals) needed to complete them. 
Sample Post-Treatment Plan 
Example Long-Term Goal:  
• Accept a promotion that involves public speaking 
Example Short-Term Goals and Strategies: 
• Give an effective presentation 
1. Offer to give a presentation in a class or meeting once per 
month/semester/quarter. 
2. Give practice speeches to friends/family once per week. 
• Take part in group discussions 
1. Speak up at least once per meeting/class (ask/answer questions, make 
comments). 
2. Offer a contrasting opinion in a class/meeting at least once per week. 
3. Respectfully disagree with a colleague or classmate once per week. 
• Facilitate a meeting 
1. Offer to present weekly reports in a meeting/class. 
2. Raise an issue for discussion twice per week. Encourage others to state 
their opinions. 
3. Offer to run a meeting for work, school, or another activity group once 
per month. 
Other Strategies Used to Meet Goals: 
• Use mindfulness meditation or other strategies (e.g., dropping the rope) to notice 
thoughts or feelings without trying to change them. 
• Pick 1 social skill to practice while engaging in each public speaking situation. 
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Post-Treatment Plan Instructions [Habituation] 
• Even though you have completed the treatment, it is important that you keep 
thinking about the goals discussed during treatment and what you still want to 
accomplish with regard to public speaking. 
• The best way to keep doing this is to list specific goals and how you will meet 
them using the skills learned in the treatment group. 
• It is important to break down bigger goals (long-term goals) into the specific steps 
or subgoals (short-term goals) needed to complete them. 
Sample Post-Treatment Plan 
Example Long-Term Goal:  
• Accept a promotion that involves public speaking 
Example Short-Term Goals and Strategies: 
• Give an effective presentation 
3. Offer to give a presentation in a class or meeting once per 
month/semester/quarter. 
4. Give practice speeches to friends/family once per week. 
• Take part in group discussions 
4. Speak up at least once per meeting/class (ask/answer questions, make 
comments). 
5. Offer a contrasting opinion in a class/meeting at least once per week. 
6. Respectfully disagree with a colleague or classmate once per week. 
• Facilitate a meeting 
4. Offer to present weekly reports in a meeting/class. 
5. Raise an issue for discussion twice per week. Encourage others to state 
their opinions. 
6. Offer to run a meeting for work, school, or another activity group once 
per month. 
Other Strategies Used to Meet Goals: 
• Engage in public speaking as often as possible, and remain in the situation as long 
as possible, to allow yourself to habituate to the anxiety. Try to stay in the 
situation until your anxiety begins to decrease (or at least until it levels off). 
• Pick 1 social skill to practice while engaging in each public speaking situation. 
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SUDS: Subjective Units of Discomfort Scale [Habituation] 
 
0 – no anxiety, calm 
 
25 – mild anxiety, able to cope 
 
50 – moderate anxiety, some trouble focusing 
 
75 – severe anxiety, thoughts of leaving situation 
 
100 – very severe anxiety, worst ever experienced 
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How is Mindfulness Meditation Beneficial? [ACT] 
(adapted from: 
http://members.iinet.net.au/~gmt/How_is_Meditation_Helpful_Blackledge.pdf) 
 
1. It teaches you how to directly experience the present moment. 
 
We spend virtually all of our time caught up in our heads, often upset about the past or 
worrying about the future.  When we're this caught up in our heads, it's as if the bad 
things that have happened or that might happen are happening right now.  Mindfulness 
exercises like meditation remind us that what's really happening right now and what  
our minds say is happening are two very different things. It gives you a chance to 
experience unpleasant emotions and thoughts in a safe setting.  We are all brought up to 
believe that unpleasant thoughts and feelings are things that need to be gotten rid of,  
things that indicate there is something wrong with us that needs to be fixed.  Activities 
like meditation give us a chance to see what happens when we don't struggle to get rid of 
these unpleasant thoughts and feelings.  While our minds usually tell us that this is  
a bad or a dangerous idea, the experiences of those who try it wholeheartedly say that it's 
not as bad as you'd expect, and that it takes less effort and comes at a much lower cost 
than struggling.    
 
2. It teaches you when and how you avoid. 
 
We've become such experts at pushing away unpleasant experiences that we often take 
steps to avoid them even before we are consciously aware they are there!  Avoidance is 
fine when it doesn't cause problems for you, but when it keeps you from moving in a 
valued direction it is counterproductive.  Mindfulness activities like meditation give you 
much better insights into what kinds of feelings you try to avoid, how you try to avoid 
them, and even some of the costs of these avoidance attempts.  As mentioned above, it 
also teaches you that you don't have to avoid in the first place!  
 
3. It teaches you that no thought or feeling is permanent. 
 
When we feel bad, we often automatically assume that we're going to feel that way 
forever (or at least for longer than we can bear).  Actually, all thoughts and feelings 
(whether pleasant or unpleasant) ebb and flow like waves on the ocean. Ironically, when 
we struggle against unpleasant feelings or otherwise try to avoid them, they usually stick 
around even longer and become even stronger!   
 
4. It gives you an opportunity to commit to a course of action and stick to it, 
regardless of how you think or feel. 
 
Once we decide what we value in life and what work we need to do in order to work 
toward those values, we very quickly find that we don't always feel like doing that work, 
or that we think we're not capable of doing the work.  Meditation can give you a very 
solid example of how you can do such work even when you don't feel like it or don't  
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think you can.  Simply commit to meditating for a set period of time, every day.  Do it 
even when you don't feel like it, don't think you are doing it right, or don't think you are 
getting anything out of it.  Treat these thoughts and feelings like you would any others  
while meditating-accept them, don't fight them, and focus back on the mindfulness 
exercise.  In return for a few minutes of your time, you get a daily lesson that you can do 
something even if your mind says no. 
 
5. It can provide an experience of calm and peacefulness. 
 
It doesn't always (especially if that's what you're trying to make happen!), but hey, it's 
nice when it does.  
 
6. It can make you feel more connected to the world and people around you.  
 
Much of the unpleasantness we experience comes from feeling separate from the 
experiences that surround us.  Meditation shows you, bit by bit, how connected we 
actually are.  You can think of feeling connected to the people and things around you in 
the moment as being a lamp connected to an electrical outlet.  Vitality, like electricity, 
flows from connectedness.  The lamp still exists when it's not plugged in, but it doesn't 
have the life that was intended for it.  Such connectedness is also at the core of 
spirituality and religion. 
 
7. It can teach you to be less judgmental of yourself and others. 
 
Bit by bit, meditation teaches you that all the negative evaluations and judgments we 
make about ourselves and others have little, if any, basis in fact.  Since efforts to "earn" 
evaluations such as "better  than", "good enough", "loveable", "happy enough", etc. are 
very often at the core of our suffering (especially when we believe we've fallen short of 
these evaluative states), learning to believe them less and less is a very productive 
process.  Those who frequently make negative evaluations of others (especially when 
they believe these evaluations) also tend to make more negative evaluations of 
themselves.  Making and believing negative evaluations also disconnects us more and 
more from our surroundings and from the present moment, destroying the vitality that 
comes from such experiences.     
 
8. It teaches you that your mind isn't very good at describing your experience.  
 
Direct experiences are much more complex than words can convey.  Try to describe a 
time where you were almost ecstatically aware of your surroundings (for example, 
walking in the woods, in a flower garden, or at the beach and noticing how brilliantly 
colorful, beautiful, and peaceful your surroundings are), or simply try to describe to 
someone a trip you took to a place he or she has never been (that is, what it was like to 
actually be there).  How close does you verbal description come to the actual experience?  
It seems pretty safe to say, "Not very close at all."  Direct experience is simply a lot 
bigger, and a lot different, than words.  More to the point, unpleasant experiences (even 
the really, really, really unpleasant ones) are often very different from what our minds tell 
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us they are.  In short, they are typically (and, in the minds of many who have experience 
with such a perspective, always) more bearable, less destructive, and more vitalizing than 
the "struggle against unpleasant experiences" option that our minds insistently offers us 
instead. 
 
9. It teaches you that words are just words, and that reality is something quite 
different. 
 
Try saying the word "milk" over and over again, out loud, for a minute or two.  When 
you first start saying it, you can almost actually see and feel the physical qualities of 
milk.   You can taste it, feel it going down your throat, feel how cold and creamy it is,  
etc.  After you've repeated the word for a minute or so, you only hear the actual sound 
that speaking the word makes.  Where'd the milk go?  It's just a word, but words have the 
ability to carry the features of the things they designate unless you take special steps  
to experience the words as they actually are.  Milk is a benign example, but what if the 
words were "I'm bad" or "I can't take this", and these words occurred along with intense 
feelings of self-loathing and desperation?   Your mind may be very convincing about the 
truth of these statements, but does your direct experience communicate the same 
message?  Like the milk, the brute force of these words tend to fade when you focus in on 
the experience that actually lies under the words and allow it to be there as it is, not as 
your mind says it is.  The feelings don't disappear, and often neither do the words,  
but the experience is always different from what your mind says it is.  If it isn't, it's 
usually a good sign that you’re still struggling and not fully settling into the experience.   
 
Meditation gives you a continuing lesson in the difference between direct experience 
and talk, and an eventually convincing lesson that direct experience simply feels much 
more real than words.  
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Sample Fear Hierarchy of Public Speaking Situations 
Please come up with your own list of feared public speaking situations. You may use as 
many of the examples listed here as you would like, and also add your own. Please make 
them as personally relevant and specific as possible. 
Examples: 
1. Giving a formal presentation on an unfamiliar topic in front of a large group 
(more than 20 people) 
2. Giving a formal presentation on a familiar topic in front of a large group (more 
than 20 people) 
3. Giving a formal presentation on an unfamiliar topic in front of a small group (less 
than 10 people) 
4. Giving a formal presentation on a familiar topic in front of a small group (less 
than 10 people) 
5. Answering questions in a group (e.g., audience questions about your presentation) 
6. Giving a toast at a wedding 
7. Giving a toast at a small dinner party 
8. Making an impromptu speech (e.g., someone asks you to talk about something 
“off-the-cuff”) 
9. Singing karaoke in a crowded bar 
10. Leading/facilitating a meeting 
11. Speaking up in a meeting or a class (giving an opinion, making an 
argument/suggestion) 
12. Answering a question in a meeting or class 
13. Debating/arguing your opinion in front of a group 
14. Leading a conference call 
15. Taking part in a conference call but not as the leader 
16. Presenting a case or report at a meeting 
17. Other performance situations (e.g., dancing, playing instruments, stand-up 
comedy) 
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MONITORING FORM [ACT—Session 1] 
Please record each of the public speaking situations that you encounter during the week, your thoughts/feelings while doing so, and 
what you did to handle these thoughts/feelings. 
 
Date/Time Describe the public speaking 
situation you encountered. 
What were your 
feelings/thoughts/bodily 
sensations while it was 
happening? 
What did you do to 
handle your feelings, 
thoughts, or bodily 
sensations? 
Anxiety 
Rating  
(0-10) 
Willingness 
Rating  
(0-10) 
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EXPOSURE EXERCISE LOG/MONITORING FORM [ACT—Subsequent Sessions] 
 
Please record each of the public speaking situations that you practiced, your thoughts/feelings while doing so, what you did to handle 
these thoughts/feelings, and the amount of time (in minutes) spent in each situation. 
 
Date/Time Describe the public 
speaking situation you 
practiced. 
Length of 
time (in 
minutes) 
spent in 
this 
situation. 
What were your 
feelings/thoughts/bodily 
sensations while it was 
happening? 
What did you do to 
handle your 
feelings, thoughts, 
or bodily 
sensations? 
Anxiety 
Rating  
(0-10) 
Willingness 
Rating  
(0-10) 
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MONITORING FORM [Habituation—Session 1]
 
Please record each of the public speaking situations that you encounter during the week. Also record your SUDS (Subjective Units of 
Discomfort) ratings before and after the public speaking situation, as well as the highest level your SUDS reached during the situation. 
 
 
Date/Time 
 
Describe the public speaking situation you encountered. 
SUDS 
Before? 
(0-100) 
SUDS 
After? 
(0-100) 
Highest 
SUDS? 
(0-100) 
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EXPOSURE EXERCISE LOG/MONITORING FORM [Habituation—Subsequent Sessions] 
 
Please record each of the public speaking situations that you practiced and the amount of time (in minutes) spent in each situation. 
Also record your SUDS (Subjective Units of Discomfort) ratings before and after the public speaking situation, as well as the highest 
level your SUDS reached during the situation. 
 
 
Date/Time 
 
Describe the public speaking situation you practiced. 
Length of time 
(in minutes) spent 
in this situation. 
SUDS 
Before? 
(0-100) 
SUDS 
After? 
(0-100) 
Highest 
SUDS? 
(0-100) 
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